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 ERRATUM 
Diet Quality and Its Association with Gestational Diabetes 
Mellitus 
Jelena Meinilä 
 
After printing of the thesis, the following error was found (3 August 
2017). The components of the Healthy Food Intake Index were in a 
wrong order in Figure 9 on page 84. The figure below replaces it. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Kappa-coefficients and their 95% confidence intervals between the 1st and 2nd trimester 
Healthy Food Intake Index (HFII) component scores (Study II, n = 122).  
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ABSTRACT 
Gestational diabetes mellitus (GDM) is increasing globally concurrently with 
obesity. It causes pregnancy complications and puts the mother and offspring at 
risk of later type 2 diabetes (T2D). Dietary intake characterized by high 
consumption of vegetables, fruits, and dietary fibre and low consumption of 
high-fat/high-sugar foods and red and processed meat are associated with lower 
risk of GDM. Studies of the association between diet in Nordic populations and 
GDM are lacking. Despite a few successful lifestyle intervention studies for 
preventing GDM, knowledge of the effect of observed dietary change on the risk 
is scanty. This thesis aims to fill this gap in knowledge. The thesis was based on 
data from the Finnish Gestational Diabetes Prevention Study RADIEL, which is 
a randomized controlled lifestyle intervention trial with diet and physical-
activity counselling. The participants were either obese or had a history of GDM, 
and they were recruited either before pregnancy or at early pregnancy. GDM 
was diagnosed by a 75 g oral glucose tolerance test (OGTT). 
Study I included analysis of nutrient intake of pregnant women at high risk of 
GDM. Nutrient intake was assessed by 3-day diet records that the women filled 
in at the 1st trimester of pregnancy. The pregnant women at elevated risk of GDM 
had fat intake of 33 (standard deviation (SD) 6) per cent from total energy (E%), 
intake of saturated fatty acids higher than recommended (12, SD 3 E%), and low 
intake of carbohydrate (46, SD 6 E%). Average intakes of vitamins D (mean 7 
μg, SD 4) and A (724 μg, SD 357), folate (282 μg, SD 85), and iron (12 mg, SD 3) 
from food sources were below the Nordic Nutrition Recommendations (NNR), 
but mean total intakes (from foods and supplements), excluding vitamin A, were 
above the recommended lower level. The proportion of users of any dietary 
supplements was 77% of the study population. 
Study II included description of the development of a diet quality index, as well 
as evaluation of its validity and reproducibility. The Healthy Food Intake Index 
(HFII) was based on a food frequency questionnaire (FFQ) containing 48 food 
items. Its purpose was to serve as an instrument for studying the level of 
adherence to the NNR in pregnant women at high risk of GDM. The 11 
components of the HFII reflected the food guidelines of the NNR, intakes of 
relevant nutrients, and characteristics known to vary with diet quality. It was 
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not significantly associated with energy intake, suggesting that it did not reflect 
the amount of food intake but the quality instead. The HFII showed 
reproducibility and its components had independent contributions to the index.  
Study III aimed to prospectively investigate the association between diet 
measured at the 1st trimester of pregnancy and GDM diagnosed at the 2nd 
trimester. HFII scores of the participants were calculated from the FFQs filled 
in at the women’s 1st trimester of pregnancy. High scores in the HFII, and thus, 
high adherence to the NNR was associated with lower glucose concentrations 2 
hours after 75 g OGTT (HFII-high vs. HFII-low ß -0.91, 95% CI -1.68; -0.13). 
In Study IV, the association between dietary change from 1st to 2nd trimester of 
pregnancy and GDM at the 2nd trimester of pregnancy was evaluated. The HFIIs 
were calculated from the 1st and 2nd trimester FFQs, and GDM was tested at the 
2nd trimester of pregnancy. Dietary changes towards the food guidelines of the 
NNR during pregnancy were associated with a lower risk of GDM (crude 
p=0.028, adjusted OR 0.83; 95% CI 0.69, 0.99; p=0.043). The association 
between change in the HFII and GDM may be attributed most to changes in 
quantity and quality of dietary fat. 
Pregnant women at high risk of GDM need dietary guidance on quality of fat as 
well as sources of vitamin A. Because of low intake, vitamin A status of Finnish 
pregnant women warrants further investigations. A diet adherent to the NNR 
during early pregnancy may be associated with a lower risk of GDM. 
Furthermore, dietary change towards the NNR during pregnancy may lower the 
risk of GDM in high-risk women. This highlights the need for adequate NNR-
based dietary intervention in early pregnancy of obese women and women with 
a history of GDM. With minor adjustments, the HFII is a promising instrument 
for maternity clinics for quick screening of pregnant women’s diet quality. 
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TIIVISTELMÄ (FINNISH ABSTRACT) 
Sekä raskausdiabetes (engl. gestational diabetes mellitus, lyh. GDM) että 
lihavuus ovat maailmanlaajuisesti kasvussa. GDM voi aiheuttaa 
raskauskomplikaatioita ja lisätä sekä äidin että lapsen riskiä sairastua 
myöhemmin muun muassa tyypin 2 diabetekseen. Paljon kasviksia, hedelmiä ja 
kuituja sekä vähän runsasrasvaisia ja –sokerisia ruokia, ja punaista ja 
prosessoitua lihaa sisältävä ruokavalio näyttäisi olevan yhteydessä pienempään 
GDM:n riskiin. Pohjoismaisessa väestössä ruokavalion ja GDM:n yhteyttä on 
tutkittu vähän. Huolimatta muutamasta onnistuneesta GDM:n ehkäisyyn 
tähtäävästä elintapainterventiotutkimuksesta, mitatun ruokavaliomuutoksen 
yhteydestä GDM:n riskiin ei ole tietoa. Tämän väitöskirjan tavoitteena oli 
vastata näihin näytön puutteisiin. Väitöskirjan aineisto on peräisin 
Raskausdiabeteksen ehkäisy elämäntapamuutoksin RADIEL -tutkimuksesta, 
joka on vuonna 2008 aloitettu satunnaistettu kontrolloitu ravitsemus- ja 
liikuntainterventiotutkimus. Tutkittavat olivat suurentuneessa GDM:n riskissä 
lihavuuden (painoindeksi ≥30 kg/m2) tai aikaisemmassa raskaudessa 
sairastetun GDM:n takia. Rekrytointihetkellä tutkittavat joko suunnittelivat 
raskautta tai olivat raskautensa alussa. GDM todettiin 75 g:n 
glukoosirasitustestillä suomalaisten Käypähoitosuositusten mukaisesti. 
Väitöskirjan osatyössä I tutkittiin suurentuneessa GDM:n riskissä olevien 
odottavien naisten ravinnonsaantia. Ravinnonsaanti arvioitiin kolmen päivän 
ruokapäiväkirjalla, jonka tutkittavat täyttivät ensimmäisellä 
raskauskolmanneksella. GDM:n riskissä olevat odottavat äidit saivat rasvaa 33 
% kokonaisenergiansaannista (E%) (SD 6), tyydyttynyttä rasvaa yli 
Pohjoismaisten ravitsemussuositusten (engl. Nordic Nutrition 
Recommendations, lyh. NNR) (12 E%, SD 3), ja vähänlaisesti hiilihydraatteja 
(46 E%, SD 6). Keskimääräinen ruoasta saatu D-vitamiinin (7 μg, SD 4), A-
vitamiinin (724 μg, SD 357), folaatin (282 μg, SD 85), ja raudan saanti (12 mg, 
SD 3) alitti NNR:n suosituksen, mutta lukuun ottamatta A-vitamiinia, kyseisten 
ravintoaineiden kokonaissaanti (ruoasta ja ravintoainevalmisteista) ylsi 
suositukseen. Vitamiini- ja kivennäisainevalmisteita tutkittavista käytti 77%. 
Tutkimuksessa II kehitettiin ruokavalioindeksi ja arvioitiin sen validiteetti ja 
toistettavuus. Healthy Food Intake Index (HFII, suom. terveellisen ruoankäytön 
indeksi) perustui ruoankäyttökyselyyn, joka sisälsi 48 ruokariviä. HFII:n 
tarkoitus oli toimia välineenä tutkittaessa kuinka hyvin GDM:n riskissä olevien 
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odottavien äitien ruokavalio noudattaa NNR:n ruoankäyttösuosituksia. HFII:n 
11 komponenttia kuvastivat ruoankäyttösuosituksia, olivat yhteydessä 
tärkeimpien ravintoaineiden saantiin, ja sellaisiin tutkittavien ominaisuuksiin, 
joiden tiedetään olevan yhteydessä ruokavalion terveellisyyteen. HFII ei ollut 
merkitsevästi yhteydessä energiansaantiin, mikä viittaa siihen, että HFII mittasi 
ruoankäytön määrän sijaan ruoankäytön laatua. Jokaisella HFII:n 
komponentilla oli itsenäinen osuus HFII-pisteissä. HFII:n toistettavuus oli 
kohtuullinen. 
Tutkimuksen III tavoitteena oli selvittää onko alkuraskaudessa HFII:lla mitattu 
ruokavalion laatu yhteydessä myöhempään, toisessa raskauskolmanneksessa 
todettuun GDM:n. HFII laskettiin ruoankäyttökyselystä, jonka tutkittavat 
täyttivät ensimmäisellä raskauskolmanneksella. Korkeat HFII pisteet, mikä 
kuvaa NNR:a lähentelevää ruokavaliota, oli yhteydessä matalampaan kaksi 
tuntia glukoosirasituksesta mitattuun plasman glukoosipitoisuuteen (HFII-
korkeat pisteet vs. HFII-matalat pisteet ß -0.91, 95%:n luottamusväli -1.68; -
0.13). 
Tutkimuksessa IV oli tavoitteena selvittää onko ruokavalion muutos 
ensimmäisen ja toisen raskauskolmanneksen välillä yhteydessä toisessa 
kolmanneksessa todettuun GDM:n. HFII laskettiin ensimmäisessä ja toisessa 
raskauskolmanneksessa kerätyistä ruoankäyttökyselyistä. Raskauden 
ensimmäisen ja toisen kolmanneksen välinen ruokavalion muutos lähemmäs 
NNR:n ruoankäyttösuosituksia oli yhteydessä pienempään GDM:n riskiin 
(vakioimaton p=0.028, vakioitu OR 0.83; 95%:n luottamusväli 0.69, 0.99; 
p=0.043). HFII-muutoksen ja GDM-riskin yhteys saattoi selittyä suureksi 
osaksi muutoksilla HFII:n rasvan määrää ja laatua mittaavilla komponenteilla.  
Koska saanti oli matalaa, suomalaisten raskaana olevien A-vitamiinin saantia 
tulisi tutkia tarkemmin. NNR:n ruoankäyttösuositusten mukainen ruokavalio 
saattaa olla yhteydessä pienempään GDM:n riskiin. Lisäksi, raskaudenaikainen 
ruokavaliomuutos kohti NNR:a saattaa pienentää lihavien ja aikaisemmassa 
raskaudessa GDM:n sairastaneiden riskiä sairastua GDM:een. Suuressa GDM:n 
riskissä oleville odottaville äideille, tulee tarjota NNR:n pohjautuvaa 
ruokavalioneuvontaa. Ohjeistuksessa tulee painottaa rasvan laadun ja 
turvallisten A-vitamiinin saantilähteiden merkitystä. Pienillä muokkauksilla 
HFII:a voitaisiin käyttää neuvoloissa odottavien äitien ruokavalion laadun 
arviointiin. 
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1. INTRODUCTION 
The prevalence of GDM is globally increasing along with obesity (Caballero 
2007). In Finland, the prevalence of GDM was up to 16% in 2015 (National 
Institute for Health and Welfare 2015). The main risk factors are high maternal 
age, obesity, history of GDM, high parity, and family history of diabetes (Teh et 
al. 2011, Collier et al. 2017). In 2014, 35% of pregnant Finnish women were 
overweight (BMI 25.0-29.9 kg/m2) and 13% were obese (BMI ≥30 kg/m2) 
(National Institute for Health and Welfare 2015). The consequences of GDM 
include pregnancy complications (Catalano et al. 2012), macrosomia of the 
newborn (Farrar et al. 2016), and increased incidence of T2D for the mother 
(Kim et al. 2002) and the offspring (Seller et al. 2016). In the mother, incidence 
of T2D within 10 years from GDM-affected pregnancy is up to 70% (Kim et al. 
2002). Later obesity and metabolic disturbances are also more likely in the 
offspring of diabetic versus non-diabetic mothers (Damm et al. 2016). The rising 
prevalence of GDM causes notable increases in health care costs to society (Kolu 
et al. 2013).  
 
According to observational studies (Tobias et al. 2012, Schoenaker et al. 2015), 
and a few lifestyle intervention studies (Jing et al. 2015, Koivusalo et al. 2016, 
Petrella et al. 2016, Bruno et al. 2017), possibly modifiable risk factors for GDM 
include physical activity and diet. Diets characterized by high consumption of 
vegetables, fruits, and high-quality carbohydrates and low consumption of high-
fat/high-sugar foods and red and processed meat are associated with lower risk 
of GDM, independent of adiposity (He et al. 2015, Tryggvadottir et al. 2016). 
Some commonly acknowledged diets with these characteristics are 
Mediterranean diet, Diet Approaches to Stop Hypertension (DASH), and diet 
adherent to the US food guidelines (Tobias et al. 2012). Evidence of the 
association between diet in Nordic countries and GDM is still lacking. In 
addition, despite the few successful lifestyle intervention studies  for prevention 
of GDM (Jing et al. 2015, Koivusalo et al. 2016, Petrella et al. 2016), knowledge 
of the effect of actual dietary change on the risk of GDM is scanty. This thesis 
aims to fill these gaps in knowledge. 
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In research of the nutrition-disease relationship, diet can be approached by a 
single-nutrient analysis or by a more comprehensive whole-diet approach 
(Marshall et al. 2014). The latter overcomes some of the complexity of nutrition 
research, which includes the following aspects. Firstly, intakes of nutrients tend 
to be intercorrelated, preventing their individual effects from being 
distinguished (Hu 2002). Secondly, nutrients may interact with each other, 
which the single-nutrient approach ignores. Thirdly, sometimes only a 
cumulative effect of several nutrients instead of an effect of a single nutrient is 
sufficiently large to be detectable (Appel et al. 1997). Fourthly, change in a diet 
is often compensated by another change, which needs to be taken into account 
when assessing the effect (Sacks et al. 1995). The main methods for the whole-
diet approach are data-driven dietary pattern analysis, performed by factor 
analysis, principal component analysis, reduced rank regression (Hu 2002, 
Schulze and Hoffmann 2006), or a researcher-driven analysis by dietary indices 
(Arvaniti and Panagiotakos 2008). We aimed to evaluate whether adherence to 
the local nutrition guidelines is associated with the risk for GDM. Dietary index 
allowed the investigation of pre-defined dietary aspects. Another aim was to 
assess change in diet quality, for which the dietary index is better suited than 
data-driven dietary pattern analysis. Here, the dietary index served for studying 
the association between a diet adherent to the NNR and GDM. The dietary 
index, the HFII, was developed as a part of this thesis. Thorough validation of 
the HFII enabled us to confidently examine the association between diet quality 
and its change and their associations with the risk of GDM.  
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2. LITERATURE REVIEW 
2.1. HISTORICAL PERSPECTIVES OF DIABETES IN 
PREGNANCY AND GESTATIONAL DIABETES 
MELLITUS 
In the 19th century, maternal mortality among women with diabetic pregnancies 
was as high as 38%, and infant perinatal mortality was 60% (Hare and White 
1977). This did not change before the 1920s, when insulin was discovered, 
leading to a dramatic decrease in maternal mortality, but a smaller drop in foetal 
mortality (Hare and White 1977). Recognition of diabetic pregnancies dates 
back to the early 19th century, when German physician Bennewitz noted glucose 
in the urine of pregnant women and continuous thirst during pregnancy 
(Mestman 2002). In 1856, Blot concluded that sugar in urine was a physiological 
phenomenon in pregnancy (Mestman 2002). This was puzzling and contributed 
to the suspicion that pregnant women may be less tolerant to carbohydrate. 
Later, Duncan (in 1881) reported a recorded series of diabetic pregnancies, and 
made fundamental remarks of how diabetes may manifest in pregnancy (Drury 
1984). In addition to the few women with overt diabetes who could become 
pregnant, he recognized that diabetes may develop during pregnancy and 
disappear after pregnancy, and that it may or may not return after pregnancy. 
In the 1940s, women who developed T2D years after pregnancy were recognized 
to have had more occurrences of foetal and neonatal mortality (Herzstein and 
Dolger 1946). These findings led to the recognition that also milder glycaemia 
during pregnancy caused adverse outcomes. The expression ‘gestational 
diabetes mellitus’ was coined in the 1950s. In the 1960s, O’Sullivan and Mahan 
(1964) found that the degree of hyperglycaemia during pregnancy was 
associated with later onset of T2D. The first interpretations for abnormal 
glucose tolerance in pregnancy by OGTT were set. The cut-off values created 
then have been used in GDM diagnosis until today. Later, in 2010, International 
Association of Diabetes and Pregnancy Study Group (IADPSG) provided new 
recommendations based on the Hyperglycaemia Adverse Pregnancy Outcome 
(HAPO) study that assessed foetal outcomes in relation to glucose tolerance 
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during pregnancy (International Association of Diabetes and Pregnancy Study 
Groups Consensus Panel et al. 2010). 
2.2. DEFINITION AND DIAGNOSIS OF GESTATIONAL 
DIABETES MELLITUS 
IADPSG in 2010 defined GDM as follows: “GDM is defined as any degree of 
glucose intolerance with onset or first recognition during pregnancy that is not 
clearly overt diabetes” (International Association of Diabetes and Pregnancy 
Study Groups Consensus Panel et al. 2010). The earlier, and still often used, 
definition “any degree of glucose intolerance with onset or first recognition 
during pregnancy” (Metzger and Coustan 1998, American Diabetes Association 
2009) was inappropriate because it did not distinguish between undiagnosed 
T2D and GDM. T2D during pregnancy is associated with a higher risk of 
complications and need for more monitoring and treatment than GDM (Ali and 
Dornhorst 2011). IADPSG, American Diabetes Association (ADA), and World 
Health Organization (WHO) currently recommend that overt diabetes be 
screened and diagnosed at 1st trimester of pregnancy if glucose values of OGTT 
exceed the thresholds of overt diabetes out of pregnancy (International 
Association of Diabetes and Pregnancy Study Groups Consensus Panel et al. 
2010, American Diabetes Association 2010, Guideline Development Group of 
World Health Organization 2013). 
 
The first evidence-based diagnostic thresholds for diagnosing GDM by OGTT 
were suggested by O’Sullivan and Mahan in 1964 (Table 1) (O'Sullivan and 
Mahan 1964). They tested 752 unselected pregnant women by 100 g OGTT and 
analysed fasting glucose, 1-hour, 2-hour, and 3-hour post-load glucose 
concentrations from sampled venous serum. Based on the predictive value of 
glucose concentrations for subsequent diabetes (T2D), they assigned mean + 2 
SDs from the mean of each fasting, 1-, 2-, and 3-hour glucose as thresholds for 
abnormal values. Their conclusion was that 29% of those whose values exceeded 
two SDs above the mean would develop diabetes within 7-8 years. They 
reasoned that threshold below that would cause economic burden and would 
cause unnecessary distress compared with the hypothetical benefit (O'Sullivan 
and Mahan 1964). In 1979, the National Diabetes Data Group (NDDG) proposed 
higher thresholds because the measurement of glucose concentrations had 
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shifted from whole blood to plasma samples (National Diabetes Data Group 
1979). In 1982, Carpenter and Coustan proposed new thresholds because of 
changing methodology of measuring plasma glucose (Carpenter and Coustan 
1982). In 2010 IADPSG provided recommendations based on the 
Hyperglycaemia Adverse Pregnancy Outcome (HAPO) study (International 
Association of Diabetes and Pregnancy Study Groups Consensus Panel et al. 
2010). The diagnostic procedure and thresholds of IADPSG were, unlike the 
thresholds proposed so far, based on foetal outcomes, which the HAPO study 
showed to be improved by lower maternal glucose values (HAPO Study 
Cooperative Research Group 2009). Adverse outcomes were found to increase 
continuously with rising glycaemia. In 2010, ADA (American Diabetes 
Association 2010) and in 2013 WHO (Guideline Development Group of World 
Health Organization 2013) endorsed these criteria. 
 
The procedures of OGTT and thresholds for pathological values differ between 
as well as within countries (McIntyre et al. 2015). The two most commonly 
applied procedures for performing OGTT are a one-step 75 g 2-hour OGTT and 
a 100 g 3-hour OGTT. The latter is a two-step procedure initiated by a 50 g non-
fasting oral glucose challenge test (GCT). Women having blood glucose 
concentration exceeding a threshold (predominantly ≥7.8 mmol/l) after 1 hour 
continue to a 100 g 3-hour OGTT. The most commonly applied diagnostic 
procedures and criteria for OGTT are presented in Table 1. Most guidelines for 
diagnosing GDM recommend screening at 24-28 weeks of gestation for all 
pregnant women (International Association of Diabetes and Pregnancy Study 
Groups Consensus Panel et al. 2010, Committee on Practice Bulletins--
Obstetrics 2013, Guideline Development Group of World Health Organization 
2013, American Diabetes Association 2014). IADPSG (International Association 
of Diabetes and Pregnancy Study Groups Consensus Panel et al. 2010), WHO 
(Guideline Development Group of World Health Organization 2013), and ADA 
(American Diabetes Association 2014) suggest that if risk factors are present an 
early screening be performed, at the 1st trimester of pregnancy, and thresholds 
of overt diabetes criteria be applied. 
 
In Finland, until 2008, screening of GDM was risk factor-based (prior GDM, 
BMI >25 kg/m2, glucosuria, age >40 years, previous macrosomic newborn 
(>4500 g), or suspected macrosomia in the current pregnancy) (Ellenberg et al. 
2017). In 2004 from all pregnant women OGTT was performed for 22.2% 
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(Lamberg et al. 2012) and in 2006 for 27.5% (Koivunen et al. 2015). From 2008 
onwards, GDM has been screened comprehensively; only women aged <25 
years, with BMI <25 kg/m2, and with no family history of GDM do not need to 
be screened. The screening is based on a 2-hour 75 g OGTT after an overnight 
fast (12 hour) at 24-28 weeks of gestation (Finnish Medical Society Duodecim 
2014). If, however, the risk is high the test is performed at 12-16 weeks of 
gestation, and if negative, the test is repeated at 24-28 weeks of gestation. Blood 
samples are collected at baseline (fasting glucose), and at one and two hours 
post glucose load. The diagnosis is given if at least one of the glucose 
concentrations is pathologic. The diagnostic thresholds are presented in Table 
1. 
 
Table 1. Recommendations for diagnostic method and thresholds for gestational diabetes mellitus.  
Criteria Approach 
FG 
mmol/l 
1-h 
mmol/l 
2-h 
mmol/l 
3-h 
mmol/l 
Diagnosis 
O’Sullivan and Mahan 
1964, VWB Two-step 5.0 9.1 8.0 6.9 
≥2 exceeding 
values 
Carpenter and 
Coustan 1982, VS 
Two-step* (100 
g load)  5.3 10 8.6 7.8 
≥2 exceeding 
values 
NDDG 1979, VP Two-step (100 g load)  5.8 10.6 9.2 8 
≥2 exceeding 
values 
WHO 2013, VWB One-step (75 g load) 5.1 10 8.5  - 
≥1 exceeding 
value 
IADPSG 2010, VP One-step (75 g load) 5.1 10 8.5  - 
≥1 exceeding 
value 
ADA 2010, VP One-step (75 g load) 5.1 10 8.5  - 
≥1 exceeding 
value 
EASD 2010, VP One-step (75 g load) 5.1  10.0 8.5  - 
≥1 exceeding 
value 
Finnish Current Care 
Guidelines 2013†, VP 
One-step (75 g 
load) 5.3 10 8.6  - 
≥1 exceeding 
value 
Sweden, (Lindqvist et 
al. 2014), VP 
Two-step‡ (75 
g load) ≥6.1  - ≥9  - 
≥1 exceeding 
value 
FG, fasting glucose; 1h, 1-hour post glucose load. VS, venous serum; VP, venous plasma; VWB, 
venous whole blood; NDDG, National Diabetes Data Group; WHO, World Health Organization; 
IADPSG, International Association of Diabetes and Pregnancy Study Groups; ADA, American Diabetes 
Association. *Two-step approach is initiated with screening by 50 g oral glucose test; exceeding the 
threshold of 7.8 mmol/l leads to step two, the 100 g OGTT. †Designed by the Finnish Medical Society 
Duodecim. ‡ Repeated random capillary plasma glucose concentration; exceeding the threshold of 9.0 
mmol/l leads to step two, the 75 g OGTT. 
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2.3. EPIDEMIOLOGY OF GESTATIONAL DIABETES 
MELLITUS 
2.3.1. PREVALENCE 
Because of varying diagnostic criteria and screening practices, comparison of 
prevalence across countries is difficult. In a study by Schneider et al. (2012), in 
advanced economies diagnosed by varying criteria, the prevalence of GDM was 
between 1.7% and 11.6%. Defined by uniform IADPSG criteria, in the 
Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) study in 2012 
including 15 centres on five continents, the overall frequency of GDM was 17.8% 
(Sacks et al. 2012) (Table 2). The highest prevalence of GDM was in California 
(25.5%), Singapore (25.1%), and Manchester, UK (24.3%). The lowest 
prevalence was in Australia (15.5% in Newcastle and 12.4% in Brisbane) and 
Israel (9.3%) (Sacks et al. 2012). The higher prevalence in the HAPO study 
largely arises from the IADPSG diagnostic criteria, which produce a higher 
prevalence of GDM than the older, albeit still used, criteria (Huhn et al. 2017). 
 
By varying diagnostic criteria, the prevalence is higher in Southern Europe than 
in Central or Northern Europe (Schneider et al. 2012). In Finland, the 
prevalence of GDM was 16% in 2015 (National Institute for Health and Welfare 
2015). Between 2004 and 2006, the prevalence of GDM was highest (14.7%) in 
central and lowest (7.9%) in southern Finland (Lamberg et al. 2012). 
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Table 2. Prevalence of gestational diabetes mellitus (GDM) by field 
centre (International Association of Diabetes and Pregnancy Study 
Group criteria) (adapted from Sacks et al. 2012). 
Centre* Participants Prevalence 
of GDM, % 
Hyperglycaemia and Adverse 
Pregnancy Outcome Study, overall 
23 957 17.8 
Bellflower, California, USA 1981 25.5 
Singapore, Singapore 1787 25.1 
Cleveland, Ohio, USA 797 25 
Manchester, UK 2376 24.3 
Bangkok, Thailand 2499 23 
Chicago, Illinois, USA 753 17.3 
Belfast, UK 1671 17.1 
Toronto, Canada 2028 15.5 
Providence, Rhode Island, USA 757 15.5 
Newcastle, Australia 668 15.3 
Hong Kong, People's Republic of 
China 
1654 14.4 
Brisbane, Australia 1444 12.4 
Bridgetown, Barbados 2093 11.9 
Petah-Tiqva, Israel 1818 10.1 
Beersheba, Israel 1631 9.3 
*Centres are listed from highest to lowest unadjusted frequency of 
GDM.  
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2.3.2. RISK FACTORS 
A list of established risk factors of GDM is presented in Table 3.  
 
Table 3. Major risk factors of gestational diabetes mellitus (GDM). 
Obesity (Collier et al. 2017) 
Maternal age (Xiong et al. 2001) 
High parity (Cypryk et al. 2008) 
Ethnicity: African, Hispanic, South or East Asian, Native American 
or Pacific Islander descent (Lawrence et al. 2008) 
Family history of GDM or type 2 diabetes (especially in first-degree 
relatives) (Solomon et al. 1997) 
History of GDM or impaired glucose tolerance (Teh et al. 2011) 
History of macrosomic baby (Cypryk et al. 2008) 
Multiple pregnancy (Rauh-Hain et al. 2009) 
 
Perhaps the most studied risk factor for GDM is obesity. In the US, in 2003-
2004 the prevalence of overweight (BMI 25.0-29.9 kg/m2) adult (≥20 years) 
women was 27%, and the prevalence of obesity (BMI ≥30.0 kg/m2) was 35.3% 
(Ogden et al. 2007). In 2014, of the European adult (≥18 years) female 
population, 54.9% were overweight and 24.5% obese. In Finland in 2014, the 
prevalence of overweight among pregnant women was 35% and of obesity 13% 
(National Institute for Health and Welfare 2015). In Finland, the average pre-
pregnancy BMI of delivering women in 2014 was 24.5 kg/m2. 
 
Examination of the relationship between smoking and GDM has yielded 
conflicting results (Solomon et al. 1997, Moore Simas et al. 2014, Collier et al. 
2017). Other possible risk factors for GDM include short stature (Moses and 
Mackay 2004), excess gestational weight gain (Hantoushzadeh et al. 2016), and 
maternal high or low birth weight (Seghieri et al. 2002). Epidemiological 
evidence suggests that also diet and physical activity are risk factors for GDM 
(Zhang et al. 2014). The incidence is higher in individuals of low socioeconomic 
status than in their high socioeconomic peers (Cullinan et al. 2012). 
20 
 
2.3.3. CONSEQUENCES 
Consequences of GDM concern both the mother and the child. These 
consequences comprise pregnancy complications (Catalano et al. 2012) and 
adverse neonatal and maternal outcomes (Figure 1). The incidence of T2D of the 
mother within 10 years from GDM pregnancy ranges between studies from 2.8% 
to 70% (Kim et al. 2002). T2D, a possible consequence of GDM for the mother 
and the child, is also a risk factor for other adverse conditions such as 
cardiovascular diseases and metabolic syndrome (Varughese et al. 2005). 
Women with a history of GDM have been found with markers for vascular events 
such as abnormal endothelial function and increased intima-media thickness of 
carotid arteries (Bo et al. 2007). GDM also causes notable increases in health 
care costs for society (Kolu P et al. 2013). 
 
 
 
 
 
 
 
 
 
 
Figure 1. Consequences of gestational diabetes mellitus for mother and offspring. T2D, type 2 diabetes. 
1(Catalano et al. 2012), 2(Farrar et al. 2015, Farrar et al. 2016), 4(Kim et al. 2002), 5(Kim et al. 2007), 
6(Pettitt et al. 1993), 7(Wright et al. 2009). 
2.3.4. GLUCOSE METABOLISM IN NORMAL PREGNANCY 
Pregnancy is a diabetogenic state characterized by insulin resistance. Insulin 
resistance represents a state with a decreased sensitivity of a tissue to the action 
of insulin (Einhorn et al. 2003). This leads to a compensatory increase in insulin 
secretion. The reason for the physiological increase in insulin resistance in 
Gestational 
diabetes mellitus 
(GDM) 
Pregnancy 
complications 1: 
- pre-eclampsia 
- spontaneous 
preterm delivery 
- Cesarean section 
Neonatal adverse outcomes 2,3: 
- large for gestational age 
- macrosomia (infant body weight      
≥4000 g) 
- respiratory distress 
- shoulder dystocia 
- hypoglycaemia of the foetus 
- increased adiposity 
Long-term adverse 
outcomes: 
- Mother: 
T2D 4 
recurrence of GDM 5 
- Offspring 
T2D 6 
high adiposity 7 
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pregnancy remains unclear, although a common and probable explanation is 
that this allows glucose to flow to the foetus instead of the mother (Lain and 
Catalano 2007). 
 
At the beginning of a normal pregnancy, insulin sensitivity is normal or 
increased (Catalano 1994). As the foetoplacental unit grows and the amount of 
secreted pregnancy hormone increases, insulin sensitivity in maternal tissues 
decreases, particularly from mid-pregnancy onwards (Newbern and Freemark 
2011). The reduction starts at approximately 20-24 weeks of gestation. The 
reduction of insulin sensitivity is mediated mainly by pregnancy and placental 
hormones such as growth hormone (Barbour et al. 2007), progesterone (Ryan 
and Enns 1988), prolactin, oestrogen, and placental lactogen (Di Cianni et al. 
2003). Placental and pituitary lactogens and prolactin influence the pregnancy-
related increases in insulin synthesis and secretion, and in beta-cell number and 
beta-cell mass of the mother (Baeyens et al. 2016). The reduction in insulin 
sensitivity may be as high as 50-80% of the non-pregnant state (Buchanan et al. 
1990). Usually insulin secretion is upregulated by 200-250% from pre-
pregnancy state (Kuhl 1991). According to the current knowledge, the degree of 
insulin resistance during pregnancy is mainly attributable to adiposity and 
genetic factors (Di Cianni et al. 2003). 
2.3.5. PATHOPHYSIOLOGY OF GESTATIONAL DIABETES MELLITUS 
If a woman is unable to compensate the increased insulin need caused by the 
increased insulin resistance, hyperglycaemia develops and leads to GDM 
(Figure 2). Outside pregnancy, a similar metabolic dysfunction is related to 
several clinical syndromes such as cardiovascular disease, T2D, and non-
alcoholic fatty liver disease (Einhorn et al. 2003). In 80% of GDM patients the 
cause of hyperglycaemia is insulin resistance in combination with inadequate 
insulin secretion (Buchanan et al. 1990). Women who develop GDM have been 
found to possess reduced insulin sensitivity already before pregnancy (Catalano 
2014). In obesity, insulin resistance is a common phenomenon (Qatanani and 
Lazar 2007), and the pregnancy-induced insulin resistance is partly additive to 
this condition. Beta-cell defects also characterize women with GDM (Catalano 
2014). The mechanisms for failure of insulin balance may also involve oxidative 
stress (Lappas et al. 2011), inflammation (Wolf et al. 2003), disorganized fat 
storage, and adipokines (Fruscalzo et al. 2015). Women who develop GDM also 
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show resistance to insulin’s effect on glucose utilization and production on top 
of the physiological insulin resistance of pregnancy (Xiang et al. 1999). 
 
Figure 2. Development of insulin resistance (IR) and change in insulin secretion (IS) in normal 
pregnancy and development of gestational diabetes mellitus (GDM). 
 
Less than 10% of women who develop GDM exhibit markers related to 
autoimmune type of ß-cell dysfunction; anti–islet cell or anti-glutamic acid 
decarboxylase antibodies (Bo et al. 2003). These women are likely to develop 
type 1 diabetes during pregnancy and often have overt type 1 diabetes after 
delivery. A rare form of GDM is monogenic diabetes, the most commonly known 
of which are the six types of maturity onset diabetes of the young (MODY). These 
include defect in hepatocyte nuclear factor-4ɑ (HNF-4ɑ), glucokinase (GCK), 
the HNF-1ɑ, insulin promoter factor-1 (IPF1), HNF-1β, and neurogenic 
differentiation factor 1 (NeuroD1) (Fajans et al. 2001). These patients usually 
are not obese, and the mutations are mainly related to a defect in ß-cell function. 
The monogenic forms count for approximately 5% of all GDM cases (Ellard et 
al. 2000, Chakera et al. 2014). 
 
The heterogeneity of the pathophysiology of GDM is not fully understood. 
Despite the higher incidence of GDM in obese women than in leaner women, 
GDM can also develop in lean women (Kautzky-Willer et al. 1997). In non-obese 
women, the underlying mechanism of the hyperglycaemic condition may be a 
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more pronounced pancreatic β-cell defect than in obese women (Li et al. 2014). 
This is supported by lower homeostatic model assessment (HOMA)-β levels of 
non-obese women with a history of GDM (Kautzky-Willer et al. 1997). A recent 
study also showed differences in insulin sensitivity and ß-cell function between 
early-onset GDM and late-onset GDM (Bozkurt et al. 2015). Women with early-
onset GDM were characterized by a higher degree of insulin resistance. Women 
with late-onset GDM showed impaired ß-cell function already at early 
pregnancy. In a study based on the RADIEL data, non-obese women with prior 
GDM showed a healthier metabolic profile than obese women but were more 
likely to develop GDM (Huvinen et al. 2016). This group of women were also 
more likely to carry a risk allele of T2D gene melatonin receptor 1b (MTNR1b) 
(Grotenfelt et al. 2016). 
2.4. NORDIC AND FINNISH NUTRITION 
RECOMMENDATIONS AND PREGNANCY 
The NNR provide daily recommended intakes (RI) for nutrients for the general 
population and for pregnant and lactating women (Nordic Council of Ministers 
2014). Compared with non-pregnant women, pregnant women require slightly 
more energy, the additional requirement being approximately 430 kJ (103 kcal) 
/d in the 1st trimester and 2245 kJ (537 kcal) /d in the 2nd trimester. For certain 
nutrients, the RIs differ between non-pregnant women (aged 18-60 years) and 
pregnant women (Table 4). The higher need during pregnancy is attributed to 
providing sufficient intake for the developing foetus. The increased needs of the 
pregnant woman can mostly be met by a healthy diet similar to that 
recommended for the general population. Special attention should, however, be 
paid to intakes of folate, vitamin D, and long-chain fatty acids because their 
intakes have been low in pregnant women in Finland (Erkkola et al. 1998, 
Arkkola et al. 2006) and in other developed countries (Blumfield et al. 2013). 
The Finnish Nutrition Recommendations (FNR) (National Nutrition Council 
2014) are based on the NNR with only a few differences. In addition to the FNR, 
complementary nutrition recommendations for families with children were 
established in Finland in 2016 and included recommendations also for pregnant 
women. The most important differences in the nutrient recommendations of the 
FNR compared with the NNR are that the FNR recommends 10 μg of vitamin D 
supplementation throughout the pregnancy for all pregnant women and 500 μg 
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instead of 400 μg of folic acid supplementation for women who are planning 
pregnancy and for all women in early pregnancy (National Institute for Health 
and Welfare 2016). The NNR does not recommend supplementation, instead 
advising 500 μg of dietary folate and only during pregnancy.  
 
The NNR and FNR additionally provide food-based guidelines for the total 
population. The main food-based guidelines of the NNR are presented in Table 
13 in the Methods section. Overall, food-based guidelines for pregnant women 
are similar to those for the general population. Some individual foods are not 
recommended during pregnancy due to possible toxicity (National Nutrition 
Council 2014). Excluding those foods from the diet is, however, unlikely to 
deteriorate the quality of the overall diet, and the foods are easily replaced by 
other similar food products within the food guidelines. 
 
Table 4. Recommended daily intake of nutrients that differ between 
non-pregnant and pregnant women (Nordic Nutrition 
Recommendations 2014). 
  Women 
aged 18-60 
years 
Pregnant 
women 
DHA, mg  - 200 
LA and ALA, E% ≥3 ≥5 
Vitamin A, RE 700 800 
Vitamin E, α-TE 8 10 
Thiamin, mg 1.1 1.5 
Riboflavin, mg 1.3 1.6 
Niacin, NE 15 17 
Vitamin B6, mg 1.2 1.4 
Folate, μg 400 500 
Vitamin C, mg 75 85 
Calcium, mg 800 900 
Phosphorus, mg 600 700 
Iron, mg 15  - 
Zinci, mg 7 9 
Copper, mg 0.9 1 
Iodine, μg 150 175 
Selenium, μg 50 60 
DHA, docosahexaenoic acid; LA, linoleic acid; ALA alpha-linoleic acid; E%, 
% from total energy intake; RE, retinol equivalent; TE, tocopherol 
equivalent; NE, niacin equivalent 
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2.5. WHOLE DIET APPROACH 
Instead of eating nutrients in isolation, people eat combinations of foods, 
rendering the study of the effects of single nutrients problematic (Willett 2012). 
Intake of nutrients or foods may be confounded by interactions and inter-
correlations with other nutrients, foods, and/or dietary patterns (Hu 2002). 
Sometimes an effect big enough to become observable may need examination of 
the cumulative effect of several dietary factors (Appel et al. 1997). Furthermore, 
when investigating dietary change, the dietary change is usually compensated 
by another change, which needs to be addressed in the analysis (Sacks et al. 
1995). 
 
Two main approaches in studying the overall diet are data-driven and 
researcher-driven analyses (Willett 2012). The data-driven dietary analysis is a 
posteriori from the collected dietary data by component analysis, factor 
analysis, cluster analysis, or reduced rank regression (Schulze and Hoffmann 
2006). The dietary data are subjected to an analysis of the correlational 
structure without pre-defined criteria. The advantage is that the resulting 
combinations of food intakes, i.e. dietary patterns, describe the overall diet as 
accurately as the scope of the underlying diet assessment method allows. The 
researcher-driven dietary analysis comprises a priori designed dietary indices. 
In this approach, before the analysis a researcher defines the aspects of the diet 
that are under examination as well as the weight of each selected dietary factor 
in the combined total index. 
2.6. DIETARY INDEX 
Dietary indices generally aim to measure the overall quality of a diet and its 
adherence to evidence-based dietary guidelines (e.g. Healthy Eating Index, HEI) 
or its contribution to a health outcome (e.g. Dietary Approaches to Stop 
Hypertension, DASH) (Fransen and Ocke 2008). The dietary measurement 
method affects the outcome of the index development because a FFQ includes a 
limited number of foods whereas diet records or diet history are more 
comprehensive in food variety and intake frequencies. On the other hand, diet 
record and diet history methods do not measure habitual intake like FFQ does. 
Dietary indices can be divided into nutrient-based, food-based, or their 
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combination (Kant 1996), and include such components as variety of the diet 
(Guenther et al. 2014) or the diet’s environmental burden (Hillesund et al. 
2014). The majority of nutrient-based indices include components such as total 
fat, SFA, or the ratio of monounsaturated fatty acid (MUFA) to SFA, cholesterol, 
and alcohol (Waijers et al. 2007, Wirt and Collins 2009). Food-based indices 
usually include at least fruits and vegetables, and cereals or grain. Decisions for 
inclusion of dietary components, cut-offs for scoring, scoring range and criteria, 
and weighting need to be made by the researcher. These are arbitrary choices 
and vary considerably between indices (Kim et al. 2003, Waijers et al. 2007). 
The cut-offs in quantifying the index components can be set statistically, for 
example, by median or tertiles. The advantage is that the groups are equal in 
size. These kinds of cut-offs vary between populations and are therefore not 
comparable across populations. Another way is to set the cut-off to a healthy 
level of intake (Waijers et al. 2007). National dietary guidelines serve as an 
evidence-based reference for indices. Many foods are not simply healthy or 
unhealthy. Thus, when setting cut-off limits factors like a U-shaped health 
benefit need to be considered. A single cut-off value may sometimes be 
problematic. Setting cut-offs based on dietary guidelines is problematic also 
when a minor proportion of the participants achieve intakes above/below the 
cut-off. This kind of non-distinguishing component is useless for the index. 
Thus, most cut-offs are at least partly attributable to the population distribution 
of the intake. The components may be weighted or unweighted, reflecting the 
contribution of each component to the overall quality of the diet. 
2.7. EVALUATION OF DIETARY INDICES 
Currently, no uniform instructions for dietary index validation exist. Different 
types of validity for health questionnaires can be distinguished as in Table 5 
(Terwee et al. 2007). All of them, however, are not applicable when considering 
diet quality indices. Internal consistency, for example, is a measure for 
unilateral questionnaires, whereas dietary pattern is a multidimensional 
construct that does not require high internal consistency. The most often seen 
methods for validity of diet quality indices include criterion validity, often 
evaluated against nutrient intake data (van Lee et al. 2016), and construct 
validity, evaluated against demographic data, many reflecting diet quality 
(Kanerva et al. 2014). Most indices are further tested in relation to a disease 
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outcome (McCullough et al. 2002, Karamanos et al. 2014). Evaluation may also 
include comparison with a biochemical marker (Bonaccio et al. 2017). 
 
 Table 5. Quality criteria for measurement properties of health status 
questionnaires (adapted from Terwee et al. 2007). 
1. Content validity 
The extent to which the domain of interest is comprehensively sampled by the 
items in the questionnaire. A clear description is provided of the measurement 
aim, the target population, the concepts being measured, and the item selection. 
Target population and investigators or experts were involved in item selection. 
2. Internal consistency 
The extent to which items in a scale are intercorrelated, thus measuring the 
same construct. 
3. Criterion validity 
The extent to which scores on a particular questionnaire relate to a gold 
standard. 
4. Construct validity 
The extent to which scores on a particular questionnaire relate to other 
measures in a manner consistent with theoretically derived hypotheses 
concerning the concepts being measured.  
5. Reproducibility 
 5.1. Agreement 
The extent to which the scores on repeated measures are close to each other 
(absolute measurement error), minimal important change (MIC) < smallest 
detectable change or MIC outside the limits of agreement or convincing 
arguments that agreement is acceptable. 
5.2. Reliability 
The extent to which patients can be distinguished from each other, despite 
measurement errors (relative measurement error),+ intra-class correlation 
coefficient (ICC) or weighted Kappa ≥0.70. 
6. Responsiveness 
The ability of a questionnaire to detect clinically important changes over time. 
7. Floor and ceiling effects 
The number of respondents who achieved the lowest or highest possible score. 
8. Interpretatability 
The degree to which one can assign qualitative meaning to quantitative scores. 
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2.8. DESCRIPTION OF SELECTED DIETARY INDICES 
The dietary indices presented in Table 6, i.e. Mediterranean Diet Quality Score 
(MED), alternate Mediterranean Diet Quality Score (aMED), HEI, alternate 
Healthy Eating Index (aHEI), DASH, and Low-Carbohydrate Diet Score (LCD), 
are related to several health outcomes (McCullough et al. 2002, Fung et al. 2005, 
Gesteiro et al. 2012, Schwingshackl and Hoffmann 2015). They have all been 
studied in relation to GDM. The original MED, reflecting the traditional diet in 
Mediterranean populations (Trichopoulou et al. 1995), has been modified to 
adapt to the US population, and is called aMED (Fung et al. 2005). DASH diet 
(Fung et al. 2008) was developed from the diet in the DASH study (Sacks et al. 
1995). HEI measures the adherence of diet to the recommendations of the USDA 
Food Guide Pyramid (Kennedy et al. 1995). aHEI incorporated characteristics 
from the original HEI with some adaptations (McCullough et al. 2002). LCD 
measure only the macronutrient distribution of the diet (Halton et al. 2006). In 
addition to the general LCD the researchers created LCDs that measured low-
carbohydrate diet with either intake of animal protein and fat sources (LCD-
animal), or vegetable protein and fat sources (LCD-vegetable). 
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Table 6. Qualitative comparison of selected dietary indices. Upward-pointing arrows represent 
scoring favouring higher intake and downward-pointing arrows scoring favouring lower intake.  
  MED 
Trichop
oulou et 
al. 1995 
aMED 
Fung et al. 
2005 
HEI  
Kenned
y et al. 
1995 
aHEI 
McCulloug
h et al. 
2002 
aHEI-2010 
Chiuve et 
al. 2012  
DASH  
Fung et 
al. 2008 
LCD 
Halton 
et al. 
2006 
Component 
       
Vegetables ↑ ↑ 
(excluding 
potato) 
↑ ↑ 
(excluding 
potato) 
↑ ↑ 
 
Legumes ↑ ↑ 
 
↑ soy 
protein 
↑ ↑ 
 
Fruits ↑ ↑ ↑ ↑ ↑ ↑ 
 
Nuts ↑ ↑ 
 
↑ ↑ ↑ 
 
Dairy ↓ 
 
↑ milk 
  
↑ low-fat 
 
Cereals ↑ ↑ whole-
grain 
↑ ↑ cereal 
fibre 
↑ whole-
grain 
↑ whole-
grain 
 
Meat/ meat 
products 
↓ ↓ red, pro-
cessed 
↑ ↑ white, 
red 
↓red, pro-
cessed 
↓red, pro-
cessed 
 
Alcohol ↑ ↑ moderate 
 
↑ moderate ↑moderate 
  
Fat ↑ 
MUFA/
SFA 
↑ MUFA/ 
SFA 
↓ TF, 
SFA, 
choles-
terol 
↓ TF, 
PUFA:SFA 
↑ n-3, 
PUFA, TF 
 
↑ 
Protein ↑ 
Carbohy-
drates 
      
↓ 
Fish 
 
↑ 
     
Sodium 
  
↓ 
 
↓ ↓ 
 
Sweetened 
beverages 
    
↓ ↓ 
 
Food variety 
  
↑ 
    
Multivitamin 
use 
 
 
 
   
↑ 
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Table 6 continues.      
Index 
property 
       
Number of 
components 
8 (fruits 
and 
nuts 
com-
bined) 
9 10 9 (nuts and 
soy protein 
combined) 
11 (nuts 
and 
legumes 
combined) 
8 (nuts 
and 
legumes 
com-
bined) 
3 
Scoring 
criteria 
median 
cut-offs 
median 
cut-offs 
propor-
tionate 
to 
guide-
lines 
proportion-
ate to 
guidelines 
proportion-
ate to 
guidelines 
quintiles 11th 
per-
centiles 
Scoring 
range 
0–8 0–9 0–100 0–87.5 0–110 8–40 0–30 
MED, Mediterranean diet score; aMED, alternate Mediterranean diet score; HEI, Healthy Eating 
Index; aHEI, alternate Healthy Eating Index; DASH, Dietary Approaches to Stop Hypertension; excl., 
excluding; TF, transfatty acids; MUFA, monounsaturated fatty acids; SFA, saturated fatty acids; 
PUFA, polyunsaturated fatty acids; n-3, omega-3 fatty acids; LCD, Low-carbohydrate diet score.  
2.9. DIET AND GESTATIONAL DIABETES MELLITUS 
2.9.1. LITERATURE SEARCH 
A literature search in the Ovid Medline database was performed on 29 March 
2016. The search command with search terms was “gestational diabetes AND 
(diet OR nutrition OR nutrition assessment OR food OR nutrient)”. The date 
range of the search was not restricted. The search produced 1548 records, and 
1529 after removing duplicates. After the first search on 29 March 2016, an 
updated search on 31 March 2017 produced 93 additional records after 
removing duplicates. Of these, three additional studies met the inclusion 
criteria. The inclusion and exclusion criteria for the studies are presented in 
Table 7.  
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Table 7. Criteria for inclusion and exclusion of studies. 
  Inclusion criteria Exclusion criteria 
Types of studies Randomized controlled trials, 
observational studies assessing 
the association between diet 
and GDM prevention.  
Case-control studies and prospective and 
cross-sectional studies where dietary 
intake was measured after diagnostic 
OGTT or the timing in relation to OGTT 
was not reported. 
Types of participants Pregnant women regardless of 
age, gestational age, parity, 
prior GDM, or BMI.  
 
Types of 
interventions 
Randomized controlled trials 
with diet or combined diet and 
physical activity interventions.  
Interventions including medication or 
dietary supplements. 
Types of exposure 
variables 
Diet, nutrient or food intake, 
dietary pattern, dietary index, 
nutrient status. 
Exposure (diet) not known to be measured 
before the diagnostic OGTT. 
Types of outcome 
measures 
GDM as primary or secondary 
outcome. 
Studies with glucose metabolism, but not 
GDM as outcome. 
Criteria 
modifications after 
database search 
All pregnant women were 
included except women with 
impaired glucose metabolism at 
baseline.  
Animal studies, missing energy-adjustment 
in the main analysis, non-randomized 
controlled trials, studies where OGTT was 
not part of the diagnosis protocol for GDM. 
GDM, gestational diabetes mellitus; OGTT, oral glucose tolerance test; BMI, body mass index. 
 
In addition to the Ovid Medline search, reference lists of the included 
publications were reviewed and any missing study meeting the inclusion and 
exclusion criteria was included in the systematic review. The numbers of each 
type of study included in the systematic review are presented in Table 8. The 
randomized controlled trials (RCT) with combined diet and physical activity 
intervention that have already been reviewed in the Cochrane systematic review 
(papers published before 11 February 2014) (Bain et al. 2015) are presented in 
Supplemental Table 1. The results of the Cochrane systematic review are 
described briefly in Section 2.9.4. 
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Table 8. Type and number of studies included in the systematic 
review of studies of diet and gestational diabetes mellitus. 
Type of study n 
Observational 22 
Prospective 19 
Cross-sectional 3 
Randomized controlled trials (not reviewed in Bain 
et al. 2015) 
17 
Diet exclusively RCTs 7 
Combined diet and physical activity RCTs 10 
Combined diet and physical activity RCTs             
reviewed by Bain et al. (2015) 
11 
RCT, randomized controlled trial.  
2.9.2. OBSERVATIONAL STUDIES 
The included observational studies are presented in Table 9 (a priori dietary 
indices and GDM), Table 10 (a posteriori dietary patterns and GDM), and Table 
12 (nutrients and foods and GDM). Twelve of the observational studies focused 
on the same cohort, the Nurse’s Health Study ІІ (NHS ІІ) cohort (Zhang et al. 
2006a, Zhang et al. 2006b, Bowers et al. 2011, Tobias et al. 2012, Bowers et al. 
2012, Chen et al. 2012, Bao W et al. 2012, Bao et al. 2013, Zhang et al. 2014, Bao 
et al. 2014a, Bao et al. 2014b, Bao et al. 2016). 
2.9.2.1. Dietary indices and gestational diabetes mellitus 
Three studies analysed the association between whole diet, measured by dietary 
indices, and GDM (Tobias et al. 2012, Zhang et al. 2014, Bao et al. 2014a) (Table 
9). They all utilized the Nurse’s Health Study II (NHS ІІ) cohort. NHS ІІ is a 
large prospective cohort from the United States in 1989 (Zhang et al. 2006a). 
The aim of the NHS II was to study dietary and lifestyle risk factors for cancer, 
heart disease, and other chronic diseases. A total of 116 430 women were 
included in the NHS II cohort. From 1991, the participants have been asked to 
fill in FFQ at four-year intervals. In the studies of the association between diet 
and GDM, participants who, in a biennially collected questionnaire, reported at 
least one singleton pregnancy that lasted >6 months from 1991 (end-points 
differing depending on the time of the analyses) were included. The last year 
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that GDM incidence was ascertained was 2001, by which time the participants 
were beyond reproductive age. The participants included in the diet-GDM 
studies were not allowed a diagnosis of earlier GDM, T2D, cardiovascular 
disease, or cancer. 
 
Tobias et al. (2012) studied the association between GDM and three different 
dietary patterns by indices; aMED, DASH, and aHEI. They found that higher 
scores of all of the indices were associated with lower risk of GDM, independent 
of pre-pregnancy BMI. They did not find any individual dietary component 
driving the association between the indices and GDM. Several components, such 
as fruit, nuts and soy, whole grains and cereal fibre, moderate alcohol, and 
decreased intakes of red and processed meats, trans-fat, and sugary beverages 
independently contributed to the diet-GDM risk. aHEI seemed to have stronger 
association with GDM than the other two dietary indices. Zhang et al. (2014) 
also studied the association between aHEI revised in 2010 (aHEI-2010, 
excluding alcohol component) and GDM and found that high scores from aHEI-
2010 were associated with lower risk of GDM. Common features between the 
diets that aMED, DASH, aHEI, and aHEI-2010 measure are high intake of fruits 
and vegetables, high carbohydrate quality, and low intake of red and processed 
meats.  
 
Bao and his colleagues (2014a) studied the association of three LCD scores 
(plain LCD, LCD-animal, and LCD-vegetable) with the risk of GDM. They found 
that pre-pregnancy LCD-animal was positively associated with GDM risk, 
whereas a pre-pregnancy LCD-vegetable was not associated with the risk. The 
association of LCD-animal score with GDM risk was no longer significant after 
adjusting for red meat, animal fat, or heme iron. This suggests that red meat, 
animal fat, and heme iron may be the main contributors to the observed 
association between LCD-animal score and GDM risk. Adjusting for vegetable 
protein and fat sources did not alter the association between LCD-vegetable and 
GDM risk. In all of the studies of the association between dietary indices and 
GDM, the associations between dietary patterns were not significantly modified 
by other risk factors of GDM such as age, parity, family history of diabetes, or 
physical activity. 
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2.9.2.2. Dietary patterns and gestational diabetes mellitus 
Four prospective (Zhang et al. 2006a, Radesky et al. 2008, Schoenaker et al. 
2015, Tryggvadottir et al. 2016) and two cross-sectional (He et al. 2015, de 
Seymour et al. 2016) studies analysed dietary patterns by factor or principal 
component analysis, or reduced rank regression in relation to GDM (Table 
10). In the 9-year follow-up of the diets of Australian women, Schoenaker et 
al. (2015) identified four dietary patterns: ‘Meats, snacks, and sweets’1, 
‘Mediterranean style’2, ‘Fruit and low-fat dairy’3, and ‘Cooked vegetables’4. 
The pre-pregnancy Meats, snacks, and sweets pattern was associated with a 
higher risk of GDM, whereas the Mediterranean dietary pattern showed a 
lower risk of GDM. Zhang et al. (2006a) described two main pre-pregnancy 
dietary patterns in the NHS ІІ cohort: “prudent”5 and “Western”6 dietary 
patterns. The prudent dietary pattern was negatively and the Western dietary 
pattern positively associated with GDM. The association between Western 
dietary pattern and GDM was driven by red and processed meat. 
Tryggvadottir et al. (2016) extracted one dietary pattern from a population of 
early-stage pregnant women, the “prudent dietary pattern”7. They found this 
dietary pattern to be associated with lower risk of GDM. Radesky et al. 
(2008) noted two main patterns in the Project Viva cohort with women in 
early pregnancy: the “prudent pattern”8, and the “Western pattern”9. In 
contrast to other dietary pattern and GDM association studies, Radesky et al. 
(2008) found no association between dietary patterns and GDM risk. 
                                                             
1 high consumption of red and processed meat, cakes, sweet biscuits, fruit juice, chocolate, and 
pizza. 
2 high consumption of vegetables, legumes, nuts, tofu, rice, pasta, rye bread, red wine, and fish. 
3 high consumption of fruits and low-fat dairy including yoghurt, low-fat cheese, and skimmed 
milk. 
4 high consumption of carrots, peas, cooked potatoes, cauliflower, and pumpkin. 
5 high consumption of fruits, green leafy vegetables, poultry, and fish. 
6 high consumption of red meat, processed meat, refined grain products, sweets and deserts, 
French fries, and pizza. 
7 high consumption of eggs, vegetables, fruits and berries, vegetable oils, nuts and seeds, pasta, 
breakfast cereals, and coffee, tea and cocoa powder, and low consumption of soft drinks and 
French fries. 
8 high consumption of vegetables, fruits, legumes, fish, poultry, eggs, salad dressing and whole 
grains. 
9 high consumption of red and processed meats, sugar-sweetened beverages, French fries, high-fat 
dairy products, desserts, butter and refined grains. 
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In a cross-sectional setting in Asian populations, De Seymour et al. (2016) 
identified three dietary patterns: “vegetable-fruit-rice-based”10, “seafood-
noodle-based”11, and “pasta-cheese-processed-meat”12 patterns. High 
adherence to the “seafood-noodle-based” dietary pattern was associated with 
a lower risk of GDM. The other two dietary patterns were not associated with 
GDM in adjusted analysis. Seafood-noodle-based dietary pattern seemed to 
include little rice, with rice replaced by noodles. The authors discuss that the 
noodle-rich dietary pattern may possess a lower glycaemic index than the 
low-noodle/high-rice dietary pattern, which could attribute to the lower risk 
of GDM with adherence to that pattern. 
Another cross-sectional study analysed dietary patterns, by reduced rank 
regression, in relation to GDM (He et al. 2015). The authors identified four 
dietary patterns: “vegetable”13, “protein-rich”14, “prudent”15, and “sweets and 
seafood”16. The vegetable pattern showed an association with a decreased risk 
of GDM, whereas the sweets and seafood pattern was associated with an 
increased risk of GDM. No association emerged for the protein-rich or 
prudent patterns. 
                                                             
10 high in vegetables, fruit, white rice, bread, low-fat meat and fish, and low in fried potatoes, 
burgers, carbonated and sugar-sweetened beverages. 
11 high in soup, fish and seafood products, noodles (flavoured and/or in soup), low-fat meat, and 
seafood, and low in ethnic bread, legumes and pulses, white rice, and curry-based gravies. 
12 high in pasta, cheese, processed meats, tomato-based and cream-based gravies. 
13 high consumption of root vegetables, beans, mushrooms, melon vegetables, seaweed, other 
legumes, fruits, leafy and cruciferous vegetables, processed vegetables, nuts, and cooking oil 
14 high consumption of poultry, red meat, animal organ meat, grains (mainly refined), processed 
meat, fish, soups, leafy and cruciferous vegetables, and eggs 
15 high consumption of dairy products, nuts, eggs, fish, soups, fruits, and low consumption of 
processed meat, sugar-sweetened beverages, and processed vegetables 
16 high consumption of Cantonese desserts, molluscs and shellfish, and sugar-sweetened 
beverages and low consumption of grains (mainly refined) and leafy and cruciferous vegetables 
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2.9.2.3. Foods and gestational diabetes mellitus 
Observational studies of foods and nutrients in relation to GDM are 
presented in Table 11. Ten prospective studies analysed intake of foods or 
food groups in relation to GDM (Zhang et al. 2006a, Radesky et al. 2008, 
Chen et al. 2009, Qiu et al. 2011a, Chen et al. 2012, Bao et al. 2013, 
Dominguez et al. 2014, Bao et al. 2014b, Bao et al. 2016, Mohanty et al. 2016). 
Six of the studies used the NHS II data (Zhang et al. 2006a, Chen et al. 2009, 
Chen et al. 2012, Bao et al. 2013, Bao et al. 2014b, Bao et al. 2016). Based on 
individual studies of each food group, the results suggest that high 
consumption of fried foods (Bao et al. 2014b), fast food (Dominguez et al. 
2014), eggs (Qiu et al. 2011a), potato (Bao et al. 2016), and sugar-sweetened 
cola beverages (Chen et al. 2009) may be associated with GDM, whereas 
seafood intake was not associated with GDM (Mohanty et al. 2016). The 
association between red and processed meat and GDM showed controversial 
results; Zhang et al. (2006) found a positive association between red and 
processed meat and GDM, whereas Radesky et al. (2008) found no 
association.  
2.9.2.4. Nutrients and gestational diabetes mellitus 
Within the included studies, four prospective studies analysed the 
association between energy-yielding macronutrients and GDM; one 
evaluated carbohydrates (Zhang et al. 2006b), one fat and fatty acid subtypes 
(Bowers et al. 2012), one protein (Bao et al. 2013), and one carbohydrates 
and fat but not protein (except in a substitution model for other nutrients) 
(Radesky et al. 2008). In addition, one cross-sectional study analysed all 
three macronutrients; carbohydrates, fat, and protein intake (Saldana et al. 
2004). 
 
Bowers et al. (2012) in a 10-year follow-up did not find an independent 
association between total fat intake and GDM. They noted that substitution 
of carbohydrates with fat increased the risk of GDM. Radesky et al. (2008) in 
a follow-up from early pregnancy found no such association in a conventional 
model or in a substitution model. Bowers et al. (2012) also reported that risk 
40 
 
for GDM was increased by substituting carbohydrates with animal fat, and 
that the risk decreased by substitution of vegetable fat for animal fat. None 
of the prospective or cross-sectional studies (Saldana et al. 2004, Zhang et al. 
2006b, Radesky et al. 2008, Bowers et al. 2012) analysing the association 
between carbohydrate intake and GDM, with adequate adjustments, found 
an association unless fat was substituted with total carbohydrate (Saldana et 
al. 2004, Bowers et al. 2012). This evidence suggests that carbohydrate 
coupled with fat and/or fibre intake is associated with GDM. Bao et al. (2013) 
in the NHS II observed an association between higher risk of GDM with 
higher animal protein, especially red meat, and lower risk of GDM with a 
higher vegetable protein intake. In a cross-sectional setting, Saldana et al. 
(Saldana et al. 2004) did not distinguish between protein sources and found 
no association between GDM risk and total protein intake in either 
conventional analysis or a substitution model. 
 
The studies focusing on the association between fat subtypes and GDM are 
few and the findings are inconsistent. While neither Bowers et al. (2012) nor 
Radesky et al. (2008) found an association between SFA intake and GDM, 
Radesky et al. did note an association between polyunsaturated fatty acid 
(PUFA) and GDM and Bowers et al. (2012) between MUFA and GDM. 
Substitution of MUFA for carbohydrates increased the risk of GDM. Bowers 
et al. (2012) and Qiu et al. (2011a) studied cholesterol intake and GDM and 
both found that cholesterol intake was significantly associated with GDM 
after adjustment for dietary and non-dietary risk factors, including specific 
fatty acids. Mohanty et al. (2016) observed no association between dietary 
EPA and DHA and GDM. 
 
In addition to the null results of Radesky et al. (2008), Zhang et al. (2006b) 
in the NHS II cohort analysed the associations between dietary fibre and 
GDM and between glycaemic load and GDM. They found that pre-pregnancy 
dietary total fibre and cereal and fruit fibre were strongly inversely associated 
with GDM risk. They further found that GDM risk increased with high 
glycaemic load, but not with high glycaemic index alone. 
 
Two prospective studies analysed iron intake (with energy adjustment) in 
relation to GDM (Bowers et al. 2011, Qiu et al. 2011b). Analysis of total iron 
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showed no association (Bowers et al. 2011), but in the analysis of heme iron, 
higher pre-pregnancy and pregnancy intakes were associated with higher 
incidence of GDM in an energy-adjusted multivariate analysis (Bowers et al. 
2011, Qiu et al. 2011b). In all of the analyses with adjustment for SFA, 
cholesterol, and red meat, the association between heme iron and GDM 
incidence remained significant (Bowers et al. 2011, Qiu et al. 2011b).
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2.9.3. INTERVENTION STUDIES WITH DIETARY COUNSELLING FOR 
PREVENTION OF GESTATIONAL DIABETES MELLITUS 
Randomized controlled trials with exclusively dietary counselling for 
prevention of GDM, published before 29 March 2016, are seven in total 
(Table 12). They include the following diet interventions: low-glycaemic 
index (LGI) diet (Moses et al. 2006, Walsh et al. 2012, Markovic et al. 2016), 
diet adherent to national nutrition recommendations (Wolff et al. 2008, 
Laitinen et al. 2009, Luoto et al. 2010), a low/moderate-carbohydrate diet 
(Thornton et al. 2009), and an intervention with undefined content 
(Quinlivan et al. 2011). The studies were started in early pregnancy. They vary 
by inclusion criteria, intervention intensity, and diagnostic criteria for GDM. 
Most of the studies included a control group that was provided only standard 
care for pregnant women (Wolff et al. 2008, Laitinen et al. 2009, Quinlivan 
et al. 2011, Walsh et al. 2012). Moses et al. (2006), however, compared LGI 
group with high-glycaemic index (HGI) group, and Markovic et al. (2016) 
LGI group with high-fibre (HF) group. Thornton et al. (2009) advised both 
control and intervention groups to walk 30 min/day. A Finnish diet 
intervention study by Luoto et al. (2010) on top of dietary counselling 
provided food products with favourable nutrient content to the intervention 
participants. Only one of the diet interventions (Quinlivan et al. 2011) 
reported significantly lower incidence of GDM in the intervention than in the 
control group. Their cut-off values for OGTT for diagnosing GDM were very 
low compared with any current criteria for GDM. What they actually 
measured was whether dietary counselling influenced glucose levels at the 
lower end of the risk spectrum. They reported increased intake of fruits, 
vegetables, and home-cooked meals and decreased intake of carbonated 
drinks, juices, and fast food. The result is in line with cohort studies where 
diets high in fruits and vegetables, and low in fast food and sugar-sweetened 
beverages have been associated with lower risk of GDM (Chen et al. 2012, 
Dominguez et al. 2014, Schoenaker et al. 2015, Tryggvadottir et al. 2016).  
 
Some of the diet intervention studies have been clearly underpowered for 
detecting a difference in GDM incidence between intervention and control 
group. Moses et al. (2006) reported only one GDM case, and Wolff et al. 
47 
 
 
(2008) reported three cases. Both studies also provided insufficient 
information on the diagnostic criteria for GDM. Four (Laitinen et al. 2009, 
Quinlivan et al. 2011, Walsh et al. 2012, Markovic et al. 2016) of the seven 
diet intervention studies provided the diagnostic criteria for GDM 
adequately. They all differed greatly by the approach taken (one-step 75 g 
glucose load or two-step 100 g glucose load), the measures included in the 
diagnosis (glucose concentration on fasting, 1-hour, 2-hour, 3-hour post-
glucose load state), and cut-off values for pathological result. The study with 
the largest number of participants is that of Walsh et al. (2012), who included 
women who had delivered a macrosomic baby in a previous pregnancy, but 
had no history of GDM. This may have been a group with lower risk for GDM 
because they had already survived one pregnancy without GDM and the 
macrosomic baby was not a result of GDM pregnancy. The incidence of GDM 
was low, and they did not find a difference between intervention and control 
groups even though the intervention group had lower glycaemic index, 
glycaemic load, and energy intake after the intervention. 
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2.9.4. INTERVENTION STUDIES WITH COMBINED DIET AND 
PHYSICAL ACTIVITY COUNSELLING FOR PREVENTION OF 
GESTATIONAL DIABETES MELLITUS 
Recently, most lifestyle interventions for GDM prevention have combined 
diet and physical activity intervention. Bain et al. (2015) reviewed the effect 
of combined diet and exercise interventions on GDM risk (Supplemental 
Table 1). Most of the studies examined were conducted in outpatient clinics 
and in Western countries. All participants were pregnant and recruited 
between 2002 and 2011. Gestational weeks at randomization varied between 
13 and 18. The studies varied in risk status of the women, mainly in BMI and 
ethnicity. The dietary interventions were implemented by 
dietitians/nutritionists, nurses, physicians, researchers, or health coaches. 
Also the number of counselling sessions, whether the sessions were 
individual or group sessions, and the dietary advice varied. The advice 
differed in energy intake targets and diet macronutrient and/or food 
composition. The advice was most often based on national nutrition 
recommendations. Type of physical activity intervention also varied; some 
offered advice and some offered exercise sessions, and the goals varied 
between the studies. GDM was the primary outcome in four of the studies. 
When those who received the intervention were compared with those who 
did not, no clear difference existed between the groups in the risk of 
developing GDM. There was, however, variation between the studies in 
quality of trials, characteristics of interventions, populations assessed, and 
outcome definitions.  
 
Since the review by Bain et al. (2015), ten combined diet and physical activity 
RCTs have been published (Table 13). The systematic search performed for 
the present review also produced one study (Bogaerts et al. 2013) published 
before the Cochraine review by Bain et al. (2015). Of the listed studies, four 
lifestyle interventions succeeded in GDM prevention (Jing et al. 2015, 
Koivusalo et al. 2016, Petrella et al. 2016, Bruno et al. 2017). One of them was 
the RADIEL study, the data of which this thesis explores (Koivusalo et al. 
2016). Two hundred ninety-three women with a history of GDM and/or a 
pre-pregnancy BMI of ≥30 kg/m2 were at <20 weeks of gestation and were 
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randomly allocated to the intervention group (n = 155) or the control group 
(n = 138) (Koivusalo et al. 2016). Each participant in the intervention group 
received individualized counselling on diet, physical activity, and weight 
control from trained study nurses and had one group meeting with a 
dietitian. The control group received standard antenatal care. At about the 
same time as the RADIEL study, Jing et al. (2015) reported success with a 
diet and physical activity intervention. They provided diet and physical 
activity counselling for pregnant women at 12 gestational weeks, who were ≥ 
18 years, who understood written Chinese, and did not have pre-existing 
diabetes. Unfortunately they did not provide details of the content of the 
dietary and physical activity counselling, diagnostic criteria for GDM, or 
whether OGTT was performed also at baseline. They reported that at 
gestational weeks 20-24, compared with the control group, the intervention 
group had higher energy and seafood intake, had lower fruit and nut intake, 
and spent less time resting. 
 
Bruno et al. (2017) also performed a diet and physical activity intervention 
study with 131 overweight participants (BMI ≥25 kg/m2). They provided 
face-to-face dietary counselling by a dietitian, the main emphasis being on 
avoiding high-glycaemic-index foods and high intake of SFA. The 
participants were also advised to perform moderate-intensity LTPA at least 
3 times per week. On top of the counselling, the study provided 6 meals/day 
that were in compliance with the diet intervention. They started the 
intervention as early as 9-12 weeks of gestation and tested for GDM at 
gestational weeks 16-18; if negative, the test was repeated at gestational 
weeks 24-28. Interestingly, the majority of the participants had a family 
history of diabetes, although information on who was reckoned as family was 
not disclosed. This and the high pre-pregnancy BMI of the women (33 ±6 
kg/m2) placed the women at higher risk for GDM than the inclusion criteria 
would suggest. 
 
Petrella et al. (2016) performed a diet and physical activity intervention study 
with 61 overweight or obese participants. Although the sample size was small, 
they succeeded in preventing GDM. The participants increased their intake 
of fruits and vegetables as well as number of snacks per day, as recommended 
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by the intervention. They also decreased their intake of sugar. The incidence 
of GDM was very high in the control group (57%) which suggests that their 
study group was at exceptionally high risk of GDM. The population was 
unique in including a high proportion of participants with Maghreb ethnicity. 
Whether the risk of GDM is higher for this ethnic group compared with white 
women is currently unknown, but ethnicity is a possible factor for high 
incidence of GDM in the population. To date the largest study is the diet and 
physical activity intervention of Poston et al. (2015) with 1555 obese 
(BMI≥30 kg/m2) pregnant women. Together with several other lifestyle 
intervention trials, it was, however, ineffective in preventing GDM. 
 
Possible explanations for the 4 studies succeeding, in contrast to the failure 
of the others, may be a different study population and study protocol. The 
study population of RADIEL was unique in including a large number of non-
obese women with a history of GDM (Koivusalo et al. 2016). These women 
may be more motivated to change their lifestyle than women without a 
history of GDM. These women may also possess a different type of 
pathophysiology in developing GDM (Huvinen et al. 2016, Grotenfelt et al. 
2016). A sub-study from the RADIEL data showed that one of the risk gene 
polymorphisms was more common in this group compared with other 
participants in the RADIEL study (Grotenfelt et al. 2016). Unlike most of the 
studies, RADIEL tested glucose tolerance at study enrolment and excluded 
the participants that had pathological OGTT (defined by GDM cut-offs) at the 
beginning of the study. Petrella et al. (2016) also performed OGTT at 
gestational weight 18 and found that all participants had normal glucose 
tolerance early in the study. Thus, RADIEL and the study by Petrella et al. 
(2016) did not include women with severe glucose intolerance in the 1st 
trimester of pregnancy, which presumably would have been followed by more 
severe glucose intolerance in the 2nd and 3rd trimesters of pregnancy as well. 
Jing et al. (2015) succeeded in preventing GDM in a population of Chinese 
women, and in the study of Petrella et al. (2016) a rather large proportion of 
the participants were from the Maghreb ethnic group. It is possible that their 
risk profile is not comparable with the risk profile of women with white 
ethnicity, which could have affected the results. Bruno et al. (2017) uniquely 
provided the majority of daily meals, which most likely improved the 
adherence of participants to the intervention protocol. Whether their success 
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in preventing GDM was because of higher adherence to the intervention 
relative to the other studies would be useful information to acquire. The 
authors report that in the intervention group 57.9% of the participants had 
consumption of vegetables, sugar, and saturated fat within the recommended 
limits at gestational week 36, whereas in the control group the proportion 
was 38.7%. A more detailed report of dietary intake before and after the 
intervention is needed to thoroughly evaluate the effect of the intervention 
on the diet. 
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2.9.5. SUMMARY OF EVIDENCE OF THE ASSOCIATION BETWEEN 
DIET AND GESTATIONAL DIABETES MELLITUS 
Results of epidemiological studies suggest that diets high in vegetables, 
fruits, and high-quality carbohydrates and low in red and processed meat and 
high-energy/nutrient-poor foods are associated with lower risk of GDM 
(Zhang et al. 2006a, Schoenaker et al. 2015, Tryggvadottir et al. 2016). Given 
the rather small number of studies (and most studies based on the same 
cohort, NHS II), it is worth keeping in mind the negative result of the well-
designed study of Project Viva (Radesky et al. 2008). The difference between 
NHS II and Project Viva is that in NHS II the dietary intake was measured 
longitudinally over a 10-year period before pregnancy, whereas in Project 
Viva the dietary intake was collected in early pregnancy. This suggests that a 
longer-term diet is more important than the diet during pregnancy. On the 
other hand, several short-term studies with follow-up from early pregnancy 
have shown an association between diet and GDM (Saldana et al. 2004, Qiu 
et al. 2011a, He et al. 2015, Tryggvadottir et al. 2016). Pregnancy diet may 
also reflect pre-pregnancy diet with little differences (Cuco et al. 2006, 
McGowan and McAuliffe 2013). Although the association between diet and 
GDM is supported by the current evidence, diet in Nordic countries and its 
association with GDM has not been investigated. Based on observational 
studies of macronutrients, it seems that the effect of a nutrient on GDM risk 
is highly dependent on other constituents of the diet (Saldana et al. 2004, 
Bowers et al. 2012, Bao et al. 2013). This supports the idea of a whole-diet 
approach, taken in the present thesis, rather than exploring the possibly 
confounded effect of individual nutrients.  
 
Results from the few (exclusively) diet intervention studies are difficult to 
compare with each other because of the markedly different study designs, 
GDM criteria, and small sample sizes (Moses et al. 2006, Wolff et al. 2008, 
Thornton et al. 2009, Markovic et al. 2016). Nevertheless, when looking at 
the diet interventions together with the several combined diet and physical 
activity interventions, it becomes obvious that preventing GDM is not simple 
and perhaps not even possible in all groups at high risk (Bain et al. 2015). The 
few success stories do, however, suggest that prevention is possible at least 
in some populations (Jing et al. 2015, Koivusalo et al. 2016, Petrella et al. 
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2016, Bruno et al. 2017). Identifying the different risk groups of GDM and 
appropriate prevention strategies for each group requires further studies. 
Despite several diet and physical activity interventions, it is currently unclear 
whether an observed dietary change is able to lower the risk of GDM as it has 
not been observed/measured in previous interventions. The successful diet 
and physical activity interventions have not adequately addressed whether 
the reduction in GDM risk was due to the effect of diet, physical activity, or 
the combination of both (Jing et al. 2015, Koivusalo et al. 2016, Petrella et al. 
2016). The present thesis aimed to answer this question by studying change 
in diet quality during pregnancy in relation to later risk of GDM.  
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3. AIMS OF THE THESIS 
The overall aim of the thesis was to gain new insight into the possible 
association between diet and risk of developing GDM. As NNR are valid in 
Nordic countries, the main interest was in the association between NNR-
adherent diet and GDM. Another aim was to develop a food-based diet 
quality index appropriate for measuring the adherence of a diet to the NNR. 
 
Specific study aims were as follows: 
 
I  To evaluate nutrient intake in early pregnancy in women at high risk of 
GDM. 
 
II  To develop and evaluate the validity of a diet quality index for 
measuring the diet’s adherence to the NNR in pregnant women at high 
risk of GDM. 
 
III To determine whether diet’s adherence to the NNR is associated with 
the risk of GDM. 
 
IV To measure dietary change during pregnancy by the HFII and to 
examine the association between the change and the risk of GDM. 
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4. METHODS 
4.1. STUDY PROTOCOL AND PARTICIPANTS 
The participants were from the RADIEL, which is a multicentre lifestyle 
intervention study conducted between 2008 and 2014 in two Southern 
Finnish districts, namely the Helsinki Metropolitan area and Lappeenranta. 
Women were recruited at primary health care centres and antenatal clinics 
as well as by newspaper advertisements and targeted social media 
announcements. In total, 472 Finnish women (in Figure 3, 203 participants 
recruited before pregnancy + 293 participants recruited during pregnancy) 
with an increased risk of GDM due to obesity (BMI ≥30 kg/m2) or a history 
of GDM were recruited. Obese women with a history of GDM numbered 81 
(17%), obese women without a history of GDM 227 (48%), and non-obese 
women with a history of GDM 164 (35%). The women were less than 20 
weeks pregnant (n=269) or were planning pregnancy (n=203). They were 
allocated to control (n=236) and intervention (n=260) separately in women 
recruited before pregnancy and women recruited during pregnancy as 
described in Figure 3. The exclusion criteria were age ≤18 years, pre-existing 
diabetes, medication influencing glucose metabolism (insulin, metformin, 
and oral corticosteroids), multiple pregnancy, physical disability, current 
substance abuse, severe psychiatric disorder, and substantial 
communication difficulties. The study-specific participant selection in this 
thesis allowed us to maximize the participant count in each of the studies (І-
VI), and therefore, the number of participants varies between studies. 
Additional inclusion and exclusion criteria applied in Studies I-IV are shown 
in the flow chart in Figure 3. Reproducibility analysis in Study III included 
only participants in the control arm; among these, only women not diagnosed 
with GDM in the 1st trimester of GDM were included. The study was 
conducted according to the guidelines laid down in the Declaration of 
Helsinki, and all procedures involving human subjects were approved by the 
Ethics Committee of the Department of Obstetrics and Gynaecology of 
Helsinki and Uusimaa Hospital District. Written informed consent was 
obtained from all participants.
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The intervention consisted of dietary and physical activity counselling once 
every trimester, and for those recruited before pregnancy, the intervention 
started before pregnancy and was provided every three months until 
conception. Women who were recruited during pregnancy had one group 
meeting with a dietitian and one individual visit to the study nurse before 
GDM screening in the 2nd trimester. Women recruited before pregnancy had 
at least two meetings with the study nurse and a possibility for at least two 
group meetings with a dietitian (the number of meetings depended on the 
length of the period between recruitment and conception). Dietary advice 
was provided by a dietitian at a group meeting and a study nurse at a one-on-
one study visit. The study nurse’s task was to encourage the participants to 
remain on the diet and to achieve physical activity goals. The counselling was 
based on the NNR (Nordic Council of Ministers 2014). The main emphasis 
was to increase the amount of fruits and vegetables, whole-grain foods, and 
fish and to limit the intake of high-energy/nutrient-poor foods. The 
participants were also advised to consume low-fat instead of high-fat dairy 
and meat, and vegetable fats instead of animal fats. The midwives also 
advised the participants to perform moderate-intensity LTPA for at least 150 
min/week and encouraged the participants to maintain an active lifestyle. 
Participants in the control arm received standard antenatal care. 
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Figure 3. Selection of the participants in Studies I-IV. RADIEL, Finnish Gestational Diabetes Prevention 
Study; HFII, Healthy Food Intake Index; OGTT, oral glucose tolerance test; FFQ, food frequency 
questionnaire. 
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4.2. DIETARY DATA 
4.2.1. MEASUREMENT TIMING 
Dietary collection methods and collection time-points in Studies I-IV are 
presented in Figure 4. 
 
 
PREGNANCY PERIOD 
  
    
  1st TRIMESTER 2nd TRIMESTER 
STUDY I DIET RECORD  
    
    
STUDY II DIET RECORD For reproducibility analysis (only 
participants in the control arm of 
the RADIEL study):  
FFQ (for calculation of HFII) FFQ  (for calculation of HFII) 
    
STUDY III FFQ (for calculation of HFII) OGTT 
    
    
STUDY IV FFQ (for calculation of HFII) FFQ (for calculation of HFII) 
   OGTT 
    
 
OTHER MEASUREMENTS included height, leisure-time physical activity, 
weight, socioeconomic status, and health and lifestyle questionnaires. 
 
Figure 4. Dietary data collection methods, their use, and time-points covered in Studies I-IV. FFQ, food 
frequency questionnaire; HFII, Healthy Food Intake Index; OGTT, oral glucose tolerance test. 
4.2.2. DIET RECORD 
Studies І and ІІ included diet record data. After enrolment in the study, all 
participants received instructions for completing a 3-day diet record, which 
they were advised to return to a study nurse at a scheduled appointment. 
Instructions for the diet records were to complete them over three 
consecutive days (two weekdays and one weekend day), use food and 
beverage labels as accurately as possible, and to report portion sizes as 
household measures, such as a teaspoon, a glass, a scoop, or as weight if 
available. Vitamin and mineral supplements were recorded. Vitamin and 
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mineral supplement intake frequency and amount were inquired. Two 
trained nutritionists assessed and entered the data from the diet records into 
a nutritional calculation software program, AivoDiet, version 2.0.1.5 (Aivo 
Finland Oy, Turku, Finland) for calculating the nutrient intake. While 
processing the data, a table of usual portion sizes helped convert household 
measures and volumes to grams (Sääksjärvi and Reinivuo 2004). The 
Finnish National Institute for Health and Welfare provided the food 
composition database in the software (www.fineli.fi). Most of the analytical 
nutrient values in the database are based on Finnish studies. Complementary 
data were provided by the Finnish food industry and international food 
composition tables. The national food composition database contains 
standard recipes that are based on recipes available in contemporary Finnish 
cookery books. If a food or recipe comparable to that in the diary was missing, 
a new recipe was implemented based on the information given in the diary. 
A separate question about supplement type, label, and utilization frequency 
provided for computing an additional variable for a nutrient intake including 
the intake from both food and supplements. These data served for calculation 
of the mean intakes of nutrients. In order to interpret/reflect the population-
level intakes, the mean nutrient intakes were presented alongside the RI of 
the FNR (National Nutrition Council 2005) that were valid during the period 
in which the food intake data were collected. During the data collection 
vitamin D fortification in dairy foods was doubled. This was taken into 
account by the researchers in the data-entering phase by creating new 
products in the software with doubled vitamin D content.  
4.2.3. FOOD FREQUENCY QUESTIONNAIRE 
Data from an FFQ were included in Studies II, III, and IV for developing and 
calculating the HFII. The participants filled in FFQs at the first study visit at 
6 to 18 weeks of pregnancy (mean gestational age 12.5 (SD 1.9) weeks) and at 
the second study visit at 22 to 30 weeks of pregnancy (mean gestational age 
26 (SD 1.9) weeks). In the FFQ, the participants were asked to think about 
their “current intake”. The FFQ included 48 food rows with 7 frequency 
options ranging from “less than once a week or never” to “more than 4 times 
per day”. In addition, there were 9 qualitative questions in the FFQ. 
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4.2.4.  HEALTHY FOOD INTAKE INDEX 
4.2.4.1. Components of the Healthy Food Intake Index 
The components for the HFII were selected in order to have them reflect the 
content of food-based guidelines of the NNR (Nordic Council of Ministers 
2014). The main food-based guidelines of the HFII are presented in Table 14. 
Twenty-one foods from the FFQ and two qualitative questions on diet were 
used for construction of the HFII. The two qualitative questions were as 
follows: “Which of the following are your usual choices for spread fat / 
cooking fat?” The options for spread fat were margarine, low-fat margarine, 
sterol margarine, butter-oil mix, or butter, and those for cooking fats were 
vegetable oil, margarine, liquid margarine, baking margarine, butter-oil mix, 
or butter. 
The HFII included 11 components of which some provided 0 or 1 points, fish 
provided 0 or 2 points, and the rest 0, 1, or 2 points, resulting in a total score 
of 0-17 (Table 14). The HFII covered the following food groups: vegetables, 
fruits and berries, high-fibre grains, fish, low-fat milk, low-fat cheese, 
cooking fat, bread fat spread, snacks, sugar-sweetened beverages, and fast 
food. 
The HFII components of snacks, sugar-sweetened beverages, fast food, 
vegetables, and fruits and berries included all foods that the FFQ includes for 
these food groups. The foods not incorporated into the index, such as coffee 
or tea, potato, soy products, internal organs, were not essential considering 
the content of the NNR. Within the main 12 food groups in the NNR food 
guidelines, three groups were missing from the HFII, namely meat, alcohol, 
and nuts and seeds (Table 14). The different types of nuts (salted / non-
salted) and meats (red / white and processed) were impossible to separate 
from each other because the questions had been presented in the FFQ 
ambiguously. Alcohol was not included in the HFII because its intake in the 
present population was marginal. The HFII included only milk from liquid 
dairy products because reliable categorization of yoghurts, based on their fat 
content, was not possible since this information had not been collected. 
Another relevant missing food group was breakfast cereals, as we could not 
classify them according to their sugar and fat content. 
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Table 14. Components and scoring of the Healthy Food Intake Index (HFII). 
NNR Guideline: Limit consumption of beverages and foods with added sugar or salt  
(Total points for the guideline 0-4) 
Snacks: candy, chocolate, pastries, chips, ice cream 
Cut-offs (tertiles): 
≤ 4 x / wk 2  
5–6 x / wk 1  
≥ 1 x / d 0 
Sugar-sweetened beverages: sugar-sweetened soft drink and juice 
Cut-off (median):  
< 1 x / wk 1  
≥ 1 x / wk 0  
Fast food: hamburgers and pizza 
Cut-off (median):  
< 1 x / wk 1  
≥ 1 x / wk 0   
NNR Guideline: Exchange ref ined cereals for whole-grain cereals (Total points for the 
guideline 0-2) 
High-fibre grains: dark bread, brown rice and pasta, porridge 
Cut-offs (Finnish Nutrition Recommendations+Consensus Panel):  
≥ 3 x / d 2  
1–2 x / d 1  
< 1 x / d 0 
NNR Guideline: Exchange butter for vegetable oils (Total points for the guideline 0-3) 
Cooking fat, scoring by fat type (NNR) 
vegetable oil/margarine/liquid margarine/no fat 1   
butter/butter-oil mix/baking margarine 0 
Bread fat spreads type, scoring by fat type (NNR): 
margarine /low-fat margarine   2       
sterol margarine*   1     
butter /butter-oil mix/ no spread   0 
NNR Guideline: Exchange high-fat dairy for low-fat dairy (Total points for the guideline 
0-3)   
Low-fat cheese, scoring by fat type (NNR):  
fat% ≤ 17  1  
fat% > 17 / no cheese 0 
Low-fat milk, scoring by fat type (NNR):  
low-fat  2  
low-fat and high-fat 1  
high-fat, no milk  0 
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Table 14 continues. 
NNR Guideline: Increase consumption of  vegetable fruits and berries (Total points for 
the guideline 0-3)   
Vegetables: vegetables, legumes 
Cut-offs (Finnish Nutrition Recommendations+Consensus Panel):  
> 2 x / d 2  
1–2 x / d 1  
< 1 x / d 0 
Fruits and berries    
Cut-offs (Finnish Nutrition Recommendations+Consensus Panel):  
≥ 1 x / d 1  
< 1 x / d 0 
NNR Guideline: Increase consumption of f ish and seafood (Total points for the 
guideline 0-2)  
Fish   
Cut-offs (Finnish Nutrition Recommendations+Consensus Panel):  
≥ 1 x / wk 2  
< 1 x / wk 0 
Total HFII score:   
maximum score 17   
NNR, Nordic Nutrition Recommendations 2012 (Nordic Council of Ministers 2014); Guidelines Limit 
consumption of processed and red meat and alcohol and Increase consumption of nuts and seeds are 
not assigned index components. 
 
4.2.4.2. Scoring of the Healthy Food Intake Index  
The scoring of the HFII is presented in Table 14. Intake frequencies of foods 
and food groups as well as habitual choices between low- and high fat foods 
(fat spread, cooking fat, milk, and cheese) were used. The scoring was set to 
reflect the ideas of food-based guidelines of the NNR when feasible. Where 
the NNR did not provide distinct numerical recommendations, we applied 
the FNR (National Nutrition Council 2014) and a consensus agreement of a 
panel of nutrition experts. 
Fat content of cheese and milk provided the basis for assigning the scores for 
those components. For cooking fat and bread fat spread components, the 
scoring was based on the participant’s choice between high and low SFA 
content. The recommendation for the number of portions per day in the FNR 
served for setting cut-offs for high-fibre grains, vegetables, fruits and berries, 
and fish. For the rest of the components (fast food, snacks, and sugar-
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sweetened beverages), numerical recommendations were unavailable from 
the NNR and the FNR, leading to use of study population medians and 
tertiles of the frequency of use as cut-offs. The intake frequencies were 
converted to times per day, which resulted in values of 0, 0.21, 0.5, 0.64, 1.5, 
3.5, and 4.5. The intake frequencies (times/d) of foods that were included in 
a component were summed. For the resulting intake frequency (times/d) of 
the component a median or tertile cut-offs were calculated. The cut-offs were 
rounded to the nearest original frequency option (0, 0.21, 0.5, 0.64, 1.5, 3.5, 
4.5). Scoring according to the cut-offs is presented in Table 14. 
4.2.4.3. Weighting of the Healthy Food Intake Index components  
Maximum score value for each component was either 1 or 2, based on a priori 
assumption of the relative importance of the category for the overall diet 
quality. Based on the latest national Findiet survey (Helldán et al. 2013), fat 
used as bread spread was considered a more important source of total and 
saturated/unsaturated fats than cooking fat. Similarly, type of milk was 
considered more than cheese to contribute to total dairy fat intake. Snacks 
component was assigned a maximum of 2 points, whereas a maximum of one 
point was assigned for both sugar-sweetened beverages and fast foods. This 
was because the snacks component included more food groups than sugar-
sweetened beverages and fast food. 
4.2.4.4. Validity of the Healthy Food Intake Index  
The validation protocol of the HFII is presented in Table 15, and the 
statistical methods are explained in detail in an upcoming separate section 
(4.5. Statistical methods). Item-analysis approach has been used in social 
sciences, for example, in testing the appropriateness of school exams (Clark 
and Watson 1995). In the context of diet quality index, item-rest correlation 
reflects discriminating power of the components of the index. 
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Table 15. Validation protocol of the Healthy Food Intake Index (HFII) among pregnant Finnish 
women at high risk of GDM: type of validity and HFII components, and adopted approach for 
evaluation. 
Reproducibility 
Question:  Does the HFII1 measured at 1st trimester adequately agree with the HFII2 
measured at 2nd trimester?  
Method: Kappa coefficients between 1st and 2nd pregnancy trimesters’ HFII 
components, intra-class correlation coefficient (ICC) for 1st and 2nd trimesters’ 
total HFII (control group only). 
Content validity 
Question:  Do the index components cover all of the food groups of the underlying 
recommendations of a healthy diet (NNR)? 
Method: Comparing the content of the HFII with NNR. 
Construct validity 
Question 1:  Does the HFII create variation in the population? 
Method: Item analysis of the HFII components: corrected item correlation and 
item mean. 
Question 2:  Is scoring independent from energy intake? 
Method: Energy intake from diet records. Comparisons between the HFII 
categories (low, moderate, high): general linear models.  
Question 3:  Does the HFII have multidimensional construct and what are the dimensions 
it measures? 
Method: Iterated principal factor analysis for the HFII components matrix. 
Components 
Question 1:  Do the components have independent roles within the HFII? 
Method: Corrected item correlation. 
Question 2:  Which components provide the highest and lowest scores? 
Method: Item mean. 
Criterion validity 
Question 1:  Does a linear trend in nutrient intake exist across the HFII categories or index 
component categories? 
Method: Statistical comparisons between the HFII categories: bootstrap-type 
general linear models with the appropriate contrast. 
Question 2:  Does the HFII distinguish between groups with known differences in diet 
quality (age, education, BMI, smoking, leisure-time physical activity)? 
                       Method: Same as for Question 1. 
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4.3. COVARIATE DATA 
The participants filled in questionnaires on their health, lifestyle habits, and 
history of pregnancies and pregnancy-related issues. The questionnaires also 
collected information on age, basic education, the highest level of education, 
current smoking (yes/no), and leisure-time physical activity (LTPA) as 
average time spent on LTPA per week. The number of years of education was 
calculated based on the reported basic and highest education. Information 
on previous GDM was based upon the subject’s medical records. BMI was 
calculated from 1st trimester weight because it was not self-reported and was 
comparable for the women recruited before and during pregnancy. BMI was 
calculated from the weight and height measured at the woman’s first visit to 
the study nurse during pregnancy. Weights measured at 1st and 2nd trimester 
visits provided data for calculating weight gain from 1st to 2nd trimester.  
Covariates included in the analysis of the association between diet and GDM 
in Studies III and IV were established risk factors for GDM; age, BMI, and 
GDM/pregnancy history (Teh et al. 2011), or factors reflecting differences in 
health status such as educational attainment (Mari-Dell'Olmo et al. 2015). In 
Study III, including LTPA and weight gain from 1st to 2nd trimester as 
covariates showed no impact on the estimates of the association between the 
HFII and variables of glucose metabolism (results not shown), and were for 
that reason omitted from the final models. In Study IV, additional 
adjustments were performed for change in LTPA, and weight gain from 1st to 
2nd trimester of pregnancy because the intervention could affect these 
variables and GDM risk. Adjustment for intervention assignment 
(intervention/control group) served for taking into account possible 
unknown effect of the intervention. In addition to the exposure variable 
(diet), the fully adjusted models included independent variables: 
Study III: age, BMI (1st trimester), and GDM/pregnancy history 
(nulliparous/parous without a history of GDM/parous with a history of 
GDM), educational attainment (years of education). 
Study IV: age, BMI (1st trimester), GDM/pregnancy history 
(nulliparous/parous without a history of GDM/parous with a history of 
GDM), change in LTPA from 1st to 2nd trimester, weight gain from 1st to 2nd 
trimester, group assignment (control/intervention). 
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4.4. DIAGNOSIS OF GESTATIONAL DIABETES 
MELLITUS 
GDM diagnosis was based on one or more pathological glucose value in a 75 
g two-hour OGTT (run by a central laboratory). The diagnostic thresholds 
were fasting plasma glucose ≥5.3 mmol/l, one-hour value ≥10.0 mmol/l and 
two-hour value ≥8.6 mmol/l (Finnish Medical Society Duodecim 2014). The 
OGTTs were conducted at gestational weeks 6-18 weeks. For excluding the 
possibility of reverse causality, in Studies III and IV, only women with normal 
OGTT at gestational weeks 6-18 were included. OGTT was repeated at 
gestational weeks 24-28. 
4.5. STATISTICAL METHODS 
The descriptive results of Studies І-ІV are presented as means with SDs, 
medians with interquartile range, or counts with percentages. The normality 
of variables was evaluated by Shapiro Wilk W test. In Studies II and III, the 
participants were divided into three groups according to their baseline (1st 
trimester) HFII. Mean (10.2 points) and SD (2.8 points) were calculated for 
the 1st trimester’s HFII scores. The first cut-off was set at a value that equals 
mean minus one SD, and the second at mean plus one SD. The cut-off values 
were rounded to the nearest integer, and the cut-off value was treated as a 
lower endpoint of a category. The resulting categories were HFII-low (scores 
0-7), HFII-moderate (scores 8-12), and HFII-high (scores 13-17). In the 
analysis of HFII change in Study IV, the HFII was treated as continuous and 
calculated from 1st and 2nd trimester HFII scores. 
In Study II, construct validity was evaluated by iterated principal factor 
analysis with varimax rotation. It was designed for the HFII components 
matrix of polychoric correlations in order to test correlations between 
categorized ordered variables. Polychoric correlation is a measure of a 
bivariate association where at least one of the variables is ordered and 
categorized from an underlying continuous normally distributed variable 
(Drasgow 2006). Item analysis of the HFII components was performed by 
analysing item discriminating power (corrected item correlation) and item 
difficulty (item mean), depicted by explanatory data analysis. Corrected item 
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correlation was estimated using polychoric or polyserial correlations. 
Reproducibility of the HFII components was evaluated from the HFII1trimester 
and the HFII2trimester using the weighted Kappa coefficient, and that of the 
total HFII using intra-class correlation coefficient (ICC) with one-way 
random-effects model. Thresholds for the Kappa coefficients were 
considered according to Landis and Koch (Landis and Koch 1977): 0 = less 
than chance agreement, 0.01-0.20 = slight agreement, 0.21-0.40 = fair 
agreement, 0.41-0.60 = moderate agreement, 0.61-0.80 = substantial 
agreement, 0.81-0.99 = almost perfect agreement. Thresholds for ICC 
coefficient were considered according to Cicchetti (1994): <0.40 = poor, 
0.40-0.59 = fair, 0.60-0.74 = good, and 0.75-1.00 = excellent. The HFII was 
analysed in the levels HFII-low (scores 0-7), HFII-moderate (scores 8-12), 
and HFII-high (scores 13-17) in order to study the association of the HFII 
with nutrient intakes and with characteristics associated with a healthy diet. 
For this analysis, nutrient intakes were standardized by subtracting the 
population mean intake from individual nutrient intake and dividing the 
difference by the SD of the population nutrient intake. Statistical 
comparisons between the categories were performed using analysis of 
variance or logistic regression analysis with linear contrasts. Bootstrap 
method was used when the theoretical distribution of the test statistics was 
unknown or when it violated the assumptions (e.g. non-normality).  
In Study III, the linearity of the GDM incidence across the HFII categories 
low (scores 0-7), moderate (scores 8-12), high (scores 13-17) was tested by 
logistic regression model with planned linear contrast. The association 
between the HFII and GDM was also analysed with HFII as a continuous 
variable ranging from 0-17 by logistic regression models. The univariate 
model was further adjusted for BMI, age, and GDM/pregnancy history 
(model 2) and additionally for educational attainment (model 3). To control 
for confounding of energy intake, a model with energy intake as independent 
variable was tested. Energy intake was derived from diet records and it 
contained 28 missing values. In the resulting smaller sample (n=119), energy 
adjustment did not change the effect estimates or p-values of the HFII 
compared with the results of an analysis in the same population (n=119) 
without energy adjustment. To confirm the previous result of no effect of 
energy intake, also multiple imputation of missing energy intake data (n=28) 
based on linear regression with age, BMI, and GDM status at 2nd trimester as 
independent variables was performed. The analysis of Study 3 was repeated 
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in the imputed data with energy adjustment included, and the results 
remained similar to the original results.  
In Study IV, associations between HFII change, as well as HFII sub-index 
changes, and the risk of GDM were analysed by logistic regression models. 
Sub-indices were developed based on the factors of Study II (Figure 7). A sum 
of the component scores that was assigned to a factor (factor loading ≥0.45) 
resulted in sub-indices Fats (low-fat cheese, low-fat milk, bread fat spread 
quality, cooking fat quality), Healthy foods (fish, vegetables, fruit and berries, 
high-fibre grains), and Unhealthy foods (snacks, fast food, sugar-sweetened 
beverages). Stata 13.1, StataCorp LP (College Station, TX, USA) statistical 
package was used for the analyses. 
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5. RESULTS 
5.1. SOCIODEMOGRAPHIC AND METABOLIC 
CHARACTERISTICS 
The characteristics of the participants of Studies I-IV in the 1st trimester of 
pregnancy are presented in Table 16. Study I included more nulliparous 
pregnant women than the other studies. Study II, in turn, included more 
women with GDM history. The participants in Study II had higher plasma 
glucose concentrations at fasting (mean 5.1, SD 0.4), 1 hour after glucose load 
(mean 7.5, SD 1.7), and 2 hours after glucose load (mean 6.2, SD 1.3) than in 
the other studies. No other differences in 1st trimester characteristics between 
the studies were present. 
Table 16. Characteristics of the participants of Studies I-IV at 1st trimester of pregnancy. 
 Study I  Study II  Study III  Study IV 
Number of 
participants 234  443  137  251 
  Mean SD   Mean SD   Mean SD   Mean SD 
Age (years) 32.3 4.7  32.4 4.5  32.3 4.3  32.2 4.4 
Education (years) 14.5 2.4  14.5 2.4  14.5 2.3  14.5 2.4 
BMI at 1st trimester 
(kg/ m2) 32.0 5.4 
 31.9 5.7  31.6 5.8  31.4 5.7 
LTPA at 1st 
trimester 
(min/week) median, 
IQR 
60.0 30 ; 150  60.0 30 ; 140  60.0 30 ; 135  60.0 30 ; 140 
PG at 1st trimester 
(mmol/l) 4.9 0.2 
 5.1 0.4  4.9 0.2  4.9 0.2 
1-hour PG (mmol/l) 7.0 1.4  7.5 1.7  7.1 1.3  7.0 1.4 
2-hour PG (mmol/l) 5.9 1.1  6.2 1.3  6.0 1.1  5.9 1.1  
           
GDM / pregnancy 
history n %   n %   n %   n % 
No 58 25  85 19  31 23  56 22 
Yes 73 32  218 49  55 40  101 40 
Nullipara 100 43   140 32   51 37   94 37 
BMI, body mass index; LTPA, leisure-time physical activity; IQR, inter-quartile range; PG, plasma 
glucose; GDM, gestational diabetes mellitus. 
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5.2. NUTRIENT INTAKE AT 1ST TRIMESTER OF 
PREGNANCY (STUDY I) 
Based on 3-day estimated food records, the mean intakes of carbohydrates, 
essential fatty acids, and dietary fibre were below the RI range or intake 
expressed as percentage of total energy intake (E%) by the FNR (Table 17). 
The mean intake of SFA was above the upper limit of the RI.  
Table 17. Macronutrient intake of pregnant Finnish women at high 
risk of GDM and the recommended intake of the Finnish Nutrition 
Recommendations (Study I, n=234). 
    Mean SD   Recommendation** 
Energy, kJ, kcal  7967 1861   
  1903 444   
Protein, E%  18 3   10-20 
Carbohydrates, E%  46 6  50-60 
Total FA:s, E%  33 6  25-35 
SFA, E%  12 3  10 
MUFA, E%  11 2   10-15 
PUFA, E%  6 1   5-10 
EFA, E%  4.5 1.3  5 
ω-3 PUFA, E%  2 0  1 
Sucrose, E%  9 4  <10 
Dietary fibre, g/MJ  2.9 0.9   3 
FA, fatty acid; SFA, saturated fatty acid; MUFA, monounsaturated 
fatty acid; PUFA, polyunsaturated fatty acid; EFA, essential fatty 
acids (linoleic acid and alpha-linolenic acid); **(National Nutrition 
Council 2005). 
 
The mean intakes of folate, vitamin D, and vitamin A from food sources 
among pregnant women were below the RI (Table 18). Except for vitamin A, 
the mean total intakes (combined food and supplement intake) of vitamins 
and minerals were above the RI. The prevalence of dietary supplement use 
among pregnant women was 77%, and the most commonly used 
supplements were vitamin D (72% of participants, n=169), folic acid (64%, 
n=149), vitamin E (57%, n=133), and vitamin C (55%, n=128). As other 
vitamin and mineral supplements, the women used iodine (45% of 
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participants), iron (41%), calcium (19%), docosahexaenoic acid (DHA) (9%), 
eicosapentaenoic acid (EPA) (10%), and vitamin A (3%). 
Table 18. Intake of vitamins and minerals from food, and from food and supplements 
in pregnant Finnish women at high risk of gestational diabetes mellitus (Study I, 
n=234). 
    From food sources   
Total from food 
and supplements     
    Mean SD   Mean SD   Rec. 
Vitamins: 
   
 
    
C mg 144 78  198 115 
 85 
 mg/MJ 19 10 26 16   
E mg 11 3  17 8 
 10 
 mg/MJ 1.3 0.3 2.1 1.2   
A μg 724 357  736 359 
 800 
 μg/MJ 92 40 93 42   
D μg 7 4  14 7 
 10 
 μg/MJ 1.0 0.6  1.8 1.0 
  
Folate/Folic acid μg 282 85  511 254 
 400 
 μg/MJ 36 9.2  66 33 
  
Calcium mg 1169 397  1256 402 
 900 
 mg/MJ 149 47  161 49 
  
Iron mg 12 3  21 15 
  - 
 mg/MJ 1.5 0.3  2.7 1.9 
  
Iodine μg 286 504  351 509 
 175 
  μg/MJ 36 55   44 56     
IQR, interquartile range; Rec., recommendation. **Finnish Nutrition 
Recommendations 2005 (National Nutrition Council 2005). 
5.3. VALIDITY AND REPRODUCIBILITY OF THE 
HEALTHY FOOD INTAKE INDEX (STUDY II) 
The mean HFII score among the 443 participants was 10.2 points (SD 2.8), 
ranging from 2 to 17. The distribution of the HFII is presented in Figure 5. 
The highest possible score of 17 was seen in three participants (0.7%). The 
HFII had a distribution not differing from normality (P=0.41), but the 
distribution was slightly negatively skewed (P=0.081) (Figure 5). 
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Figure 5. Distribution of the Healthy Food Intake Index scores in women at high risk of gestational 
diabetes mellitus (Study II, n=443). 
5.3.1. CONTENT VALIDITY 
The food groups addressed in the NNR food guidelines (Nordic Council of 
Ministers 2014), apart from alcohol, processed and red meat, and nuts, were 
covered by the HFII (Table 14). Measurement aim of the HFII, i.e. level of 
adherence to the NNR, has been provided. The concepts that were being 
measured, i.e. the HFII components, which reflected the food guidelines of 
the NNR, were provided. Item selection was thoroughly described. The target 
population as well as investigators and experts were involved in the index 
development process. 
5.3.2. CRITERION VALIDITY 
The energy-adjusted intakes of the macronutrients, including SFA, MUFA, 
and PUFA, and the intakes of fibre, sucrose, food-originating vitamins A, D, 
E, and folate showed linearity across the HFII categories (HFII-low, HFII-
moderate, and HFII-high) (Figure 6). The intake of energy was not 
significantly associated with the HFII categories (P=0.24). This is an 
indication that the HFII measures diet quality instead of diet quantity. The 
nutrient intakes in the HFII-component categories for each component are 
presented in Supplemental Figure 1. The components fish, low-fat milk, 
bread fat spread, and snacks provided the highest scores, and low-fat cheese 
provided the lowest scores. All of these components reflected the intake levels 
of SFA and PUFA. 
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Figure 6. Standardized intake of A) energy, energy-yielding nutrients, and dietary fibre, and B) vitamin 
and minerals in categories (low: 0-7, moderate: 8-12, high: 13-17) of the Healthy Food Intake Index 
(HFII) among pregnant Finnish women at high risk of gestational diabetes mellitus (Study II, n=251). 
CHO, carbohydrate; PUFA, polyunsaturated fatty acids; MUFA, monounsaturated fatty acids; SFA, 
saturated fatty acids; Vit., vitamin. Differences tested by bootstrap-type analysis of variance with linear 
contrast. Statistically significant at level *P<0.05, **P<0.01, ***P<0.001. 
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Educational attainment (years of education) (p=0.0045) and LTPA 
(p=0.038) increased linearly across the HFII categories. BMI (p=0.0098) 
and smoking (0.0079) decreased linearly across the HFII categories, whereas 
age (p=0.18) did not show a significant trend. 
5.3.3. CONSTRUCT VALIDITY 
Based on factor analysis for the HFII component matrix, within all of the 
HFII components (Figure 7), the HFII was identified to measure three 
distinct factors that explained most of the variation (59%) within the score. 
The first factor was characterized by high loadings for the components 
cooking fat, bread fat spread, low-fat cheese, and low-fat milk (factor named 
Fat). The second was characterized by high loadings for high-fibre grains, 
vegetables, fruits and berries, and fish (factor named Healthy foods). The 
third factor was characterized by high loadings for snacks, sugar-sweetened 
beverages, and fast food (named Unhealthy foods). Factor analysis displayed 
the correlational structure of the HFII components. Factor analysis providing 
more than one factor that explains variance in the population suggests that 
the HFII is not a unilateral construction. In a multilateral construction, factor 
analysis combining food groups whose consumption is known to vary 
together is further evidence of the HFII measuring existing structures (by 
theory) of dietary patterns. 
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Figure 7. Healthy Food Intake Index (HFII) components, factor loadings, and factors among pregnant 
Finnish women at high risk of gestational diabetes mellitus (Study II, n=443). 
5.3.4. COMPONENTS 
From the HFII, the components low-fat milk, fish, fat spread, and snacks 
provided the highest scores (Figure 8). Low-fat cheese provided the lowest 
scores. The maximum item-rest correlation coefficient of a component with 
the rest of the components was 0.31, snacks having the lowest item-rest 
correlation coefficient (0.03). The quantity of item-rest correlation 
coefficients was similar, and item means were close to each other for high-
fibre grains and vegetables. This prevents us from interpreting whether they 
have independent roles in the HFII. However, the component scores of high-
fibre grains and vegetables reflected nutrient intakes of different magnitude 
(Supplemental Figure 1), which shows that they had at least some 
independency. All components produced variation within the study 
population and independently contributed to the total score, but for high-
fibre grains and vegetables independency may have been weak. 
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Figure 8. Item-analysis of the components of the Healthy Food Intake Index (HFII) among pregnant 
Finnish women at high risk of gestational diabetes mellitus (Study II, n=443). X-axis represents the 
mean score that the participants got from the component, and the Y-axis represents the correlation of 
a component to the rest of the components. The dashed line represents the mean score of all of the 
components. 1=Snacks, 2=Low-fat cheese, 3=Fish, 4=Low-fat milk, 5=Vegetables, 6=Fruits and 
berries, 7=Sugar-sweetened beverages, 8=High-fibre grains, 9=Fast food, 10=Bread fat spread, 
11=Cooking fat.
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5.3.5. REPRODUCIBILITY 
Weighted Kappa coefficients between the HFII1trimester and the HFII2trimester 
components ranged from 0.41 to 0.69 (Figure 9), suggesting moderate to 
substantial agreement (Landis and Koch 1977). The ICC between the 
HFII1trimester and the HFII2trimester was 0.85 (95% CI 0.79 to 0.90), which 
suggests excellent agreement between the measures (Cicchetti 1994). 
 
 
Figure 9. Kappa-coefficients and their 95% confidence intervals between the 1st and 2nd trimester 
Healthy Food Intake Index (HFII) component scores (Study II, n = 122). 
5.4. HEALTHY FOOD INTAKE INDEX AND RISK OF 
GESTATIONAL DIABETES MELLITUS (STUDIES III 
AND IV) 
5.4.1. ASSOCIATION BETWEEN HEALTHY FOOD INTAKE INDEX AND 
GESTATIONAL DIABETES MELLITUS (STUDY ІІІ) 
The number of participants who developed GDM in the HFII categories were 
7 (29%) in the lowest, 18 (21%) in the mid, and 4 (14%) in the highest category 
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(p for linearity=0.17). The odds for developing GDM decreased when moving 
from the lowest HFII category to the higher categories, but the linearity 
across the categories did not reach significance with (OR 0.91; 95% CI: 0.78; 
1.06) or without (OR 0.95; 95% CI: 0.81; 1.10) adjustments (Figure 10). After 
adjustment for BMI, age, GDM/pregnancy history, and educational 
attainment, the HFII was inversely associated with glucose concentrations 
(mmol/l) at fasting (HFII-high vs. HFII-low: ß -0.14, 95% CI: -0.31; 0.01, 
non-significant) and at 2-hours post glucose load (HFII-high vs. HFII-low ß 
-0.91, 95% CI: -1.68; -0.13), but not at 1-hour post load (HFII-high vs. HFII-
low ß -0.27, 95% CI: -1.18; 0.58). The HFII sub-indices Fat, Healthy foods, 
and Unhealthy foods showed no significant association with the risk of GDM 
(results not shown). 
 
 
Figure 10. Adjusted predictions of gestational diabetes mellitus (GDM) incidence in the Healthy Food 
Intake Index (HFII) categories of low (0-7), moderate (8-12), and high (13-17) among pregnant women 
at high risk of GDM (Study III, n=137). P for linearity across the HFII categories tested by logistic 
regression analysis with linear contrast. 
5.4.2. ASSOCIATION BETWEEN CHANGE IN HEALTHY FOOD 
INTAKE INDEX AND GESTATIONAL DIABETES MELLITUS 
(STUDY IV) 
The mean HFII score for the 251 participants at baseline was 10.1 (SD 2.8), 
and the mean HFII change from 1st to 2nd trimester of pregnancy was 0.35 
P for linearity = 0.09 
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(SD 2.16) points. The HFII captured dietary changes of magnitudes from -6 
to 6 points between 1st and 2nd trimesters (Figure 11).  
 
When the women were divided into groups by baseline HFII (HFII-low, 
HFII-moderate, and HFII-high), the change in the HFII was less favourable 
in GDM-affected than GDM-non-affected participants at all baseline levels 
(Figure 12). In the total population, the HFII score decreased, i.e. the 
adherence to the NNR decreased, from 1st to 2nd trimester of pregnancy in 
women who developed GDM (Figure 12). In contrast, the HFII improved in 
women who did not develop GDM.  
Figure 11. Distribution of the Healthy Food Intake Index (HFII) changes (index points) from 1st to 2nd 
trimester of pregnancy in women at high risk of gestational diabetes mellitus (Study IV, n=251). 
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Figure 12. Change in the Healthy Food Intake Index (HFII) in total study population and according to 
baseline HFII score level (I=low, II=moderate, III=high), in gestational diabetes mellitus (GDM)-affected 
and GDM-non-affected pregnant high-risk women from 1st to 2nd trimester of pregnancy (Study IV, 
n=251). 
A higher change in the HFII score from 1st to 2nd trimester of pregnancy 
produced significantly lower odds for GDM (OR 0.83; 95% CI 0.69, 0.99; 
p=0∙043) in the adjusted model (Figure 13). Concurrently in the model, the 
1st trimester HFII was not associated with GDM (OR 0.97; 95% CI: 0.84, 1.11), 
suggesting that the 1st trimester HFII did not drive the association between 
HFII change and GDM. Only previous GDM from the other variables in the 
model was significantly associated with GDM in the index pregnancy (Table 
19). Table 19 shows the association between HFII change and GDM 
separately according to parity, previous GDM, and group assignment 
(intervention/control). The direction of the association was the same in all 
groups examined. 
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Figure 13. Association between change in HFII (points) and gestation diabetes risk (Log(OR) and 95% 
confidence interval) in obese women and women with a history of gestational diabetes mellitus. The 
model is adjusted for baseline HFII (or HFII-Fat/HFII-Healthy foods/HFII-Unhealthy foods), age, BMI, 
GDM/-pregnancy history, weight change from 1st to 2nd trimester, LTPA change from 1st to 2nd trimester, 
and group assignment (control/intervention) (Study IV, n=251). 
 
For a one-unit (points) increase, a favourable change, in HFII-Fat from the 
1st to 2nd trimester of pregnancy, the adjusted odds for GDM decreased by 
0.72 (95% CI: 0.52, 1.01, p=0∙058). Changes in the HFII-Healthy foods 
(p=0∙40) and in the HFII-Unhealthy foods (p=0∙33) were not significantly 
associated with risk of GDM. 
 
Table 19. Association between HFII change and 
GDM stratified by parity, previous gestational 
diabetes mellitus (GDM), and group assignment 
(Study IV). 
  OR 95% CI 
Parity   
Nulliparous 0.92 0.69, 1.22 
Parous 0.80 0.66, 0.98 
Previous GDM   
Yes 0.87 0.69, 1.09 
No 0.84 0.67, 1.07 
Group assignment   
Intervention 0.85 0.69, 1.04 
Control 0.83 0.65, 1.05 
 
-1.0 -0.8 -0.6 -0.4 -0.2 0.0 0.2 0.4 0.6
Log(OR)
p=0.043
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6. DISCUSSION 
6.1. MAIN FINDINGS  
6.1.1. NUTRIENT INTAKE OF PREGNANT WOMEN AT HIGH RISK OF 
GESTATIONAL DIABETES MELLITUS (STUDY I) 
In Study I, pregnant women at elevated risk of GDM had a higher than 
recommended mean intake of SFA and a low intake of carbohydrate. Average 
intakes of vitamins D and A, and folate from food sources were below the 
Finnish Nutrition Recommendations, but total intakes (from foods and 
supplements), excluding vitamin A, were above the recommended lower 
level. Most pregnant women used dietary supplements, mainly vitamin D, 
folic acid, and vitamins E and C. 
6.1.2. HEALTHY FOOD INTAKE INDEX (STUDY II) 
The HFII reflected the food guidelines of the NNR, intakes of relevant 
nutrients, and characteristics known to vary with diet quality. It was not 
associated with energy intake, i.e. quantity of food, its components had 
independent contributions to the HFII, and it exhibited reproducibility. The 
main shortcomings were absence of the red and processed meat component 
and validation in a selected study population. 
6.1.3. ASSOCIATION BETWEEN HEALTHY FOOD INTAKE INDEX AND 
GESTATIONAL DIABETES MELLITUS (STUDY III) 
High early pregnancy scores in the HFII, and thus, high adherence to the 
NNR, was associated with glucose concentration 2 hours after a 75 g OGTT. 
The association of the HFII with GDM could not, however, be confirmed. 
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6.1.4. ASSOCIATION BETWEEN CHANGE IN HEALTHY FOOD 
INTAKE INDEX AND GESTATIONAL DIABETES MELLITUS 
(STUDY IV) 
Dietary changes towards the food guidelines of the NNR during pregnancy 
were associated with lower risk of GDM. The association between change in 
the HFII and GDM may be attributed most to the change in quantity and 
quality of dietary fat. 
6.2. METHODOLOGICAL CONSIDERATIONS  
6.2.1. PARTICIPANTS 
The study group in this thesis represents a large proportion of pregnant 
Finnish women; approximately one-third of Finnish women of childbearing 
age are either overweight or obese (National Institute for Health and Welfare 
2015), and the prevalence of GDM is 12-16% (O'Sullivan et al. 2011, National 
Institute for Health and Welfare 2015). Thus, although the results cannot be 
generalized to the entire general population of pregnant women, they can be 
generalized to a notable proportion. In addition, normal-weight women with 
a history of GDM have not been investigated much in relation to risk of GDM, 
which makes the study population of this thesis unique.  
The participants in Studies III and IV were more selected than the 
participants of Studies I and II because women with pathologic OGTT in the 
1st trimester were excluded to prevent reverse causality. Studies III and IV 
cannot be generalized to all participants at high risk of GDM, but to only 
those with normal glucose tolerance at early pregnancy. The participants 
were also mainly white European women, and therefore, the results cannot 
be generalized to other ethnic groups. As in all research based on voluntary 
participation, possibly more health-conscious and educated women 
participated in the RADIEL study compared with the general population 
(Knapstad et al. 2016). Those who returned diet records might have been 
more motivated and/or health-conscious than those who did not. The 
background characteristics of the RADIEL participants who returned diet 
records and those who did not were, however, similar (Meinila et al. 2016). 
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Study IV included both control and intervention groups. The intervention 
group did not represent a general GDM-risk group of pregnant women, but 
one which had received dietary and exercise counselling and extra attention 
from health care professionals. The statistical model in Study IV was adjusted 
for LTPA change (a possible consequence of the intervention), and 
additionally for intervention assignment (control/intervention) to take into 
account possible unknown effects of the intervention. In addition, the 
direction of the association of the HFII change and GDM was similar between 
control and intervention groups.  
6.2.2. SETTING 
The longitudinal setting of Studies III and IV was a strength. The longitudinal 
setting allowed change within an individual to be studied instead of 
differences between individuals, which cannot be assumed to reflect true 
change. Although the observational setting does not allow conclusions on 
causality because of possible residual confounding (Fewell et al. 2007), the 
measure of change provided stronger evidence of causality than measure at 
one time point would have provided (Singer and Willett 2003). This is 
because change in time within an individual excludes any unobserved time-
invariant differences between individuals, and as a consequence reduces 
residual confounding. Earlier observational studies have either prospectively 
evaluated association of a diet measured at one time point before or during 
pregnancy (Radesky et al. 2008, He et al. 2015, Tryggvadottir et al. 2016) or 
examined long-term diet preceding pregnancy with GDM (Tobias et al. 2012, 
Zhang et al. 2014, Bao et al. 2014a). Thus, a novel and more optimal approach 
was applied in Study IV, where we evaluated the change from 1st to 2nd 
trimester of pregnancy.  
Although we measured the association between glucose metabolism and diet 
during pregnancy, differentiating between the effect of pre-pregnancy diet 
and pregnancy diet is difficult. Dietary patterns during pregnancy may follow 
the pre-pregnancy diet with only minor changes (Cuco et al. 2006, Crozier et 
al. 2009b). So, in Study III we cannot conclude that the association between 
diet adherent to NNR and glucose concentrations concerns exclusively the 
diet during pregnancy. Study IV resolves this issue, however, by providing 
information on dietary change precisely during pregnancy. 
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6.2.3. SAMPLE SIZE 
The sample sizes of the four studies were rather small, especially for Studies 
III and IV. Populations of other similar studies have been larger (Tobias et 
al. 2012, Zhang et al. 2014, Bao et al. 2014a). For validity analysis, according 
to Willett (Willett 2012) who recommends 100-200 participants, the study 
population of Study II was sufficient. For Studies ÍII and IV, the small sample 
size could partly explain the large confidence intervals and borderline p-
values. It is possible that the power in Study III was insufficient for detecting 
differences between GDM and non-GDM women. 
6.2.4. FOOD AND NUTRIENT MEASUREMENT 
Diet record measures short-term intake, but on a population level it is 
acceptable for measuring mean intakes (Willett 2012). It is thus an 
appropriate tool for Study I. A longer than 3-day diet recording period may 
be necessary for assessing the intake of vitamin A at individual but also at 
population level (Basiotis et al. 1987), as a diet record may under-represent 
foods consumed regularly but infrequently (Dodd et al. 2006). In the case of 
vitamin A, this may not apply in the present study because pregnant women 
are advised to avoid foods with high amounts of vitamin A (i.e. liver) (Nordic 
Council of Ministers 2014). Because of the short-term data provided by the 
diet record, it is not completely comparable with a method that measures 
habitual intake at individual level but also at population level. This may have 
caused some bias in Study I, as well as in Study II, where the HFII scores 
(based on FFQ) were compared with nutrient intakes from diet records. 
Using consecutive days in measuring dietary intake can produce misleading 
information of within-person variation of intake (Hartman et al. 1990). The 
diet records were not checked by research personnel when they were 
returned. In case of missing recipes and portion sizes, we therefore used 
standard recipes and portion sizes provided by the National Health Institute 
for Health and Welfare (https://fineli.fi). This may have caused an 
underestimation of between-person variation in the nutrient intake data of 
Study I. It could have also biased the association between nutrient intake and 
HFII in Study II. 
The FFQ that we used was not designed for estimating nutrient intake and 
for that reason only food intake frequencies were estimated from it.  
93 
 
Participants were asked to think about the “current” period when filling in 
the FFQ. Different interpretations of the reference period may have biased 
the results of Studies II-IV. The FFQ was non-validated, which may have 
affected the accuracy of the HFII scores. This is, however, at least partly 
compensated by testing validity and reliability of the HFII. The FFQ was 
missing some foods representative of the overall diet. For the dietary index 
to represent the NNR, separate questions for white and red meat should have 
been provided. The FFQ is possibly not the best measurement tool for dietary 
change because it does not take into account portion sizes but only intake 
frequencies. Therefore, changes in portion sizes cannot be detected by the 
FFQ. In validation studies, FFQs have been shown to possess low 
responsiveness to change (Slimani et al. 2015). 
The participants of this thesis have two important characteristics related to 
under-reporting of eating, namely pregnancy and obesity (Heitmann and 
Lissner 1995, McGowan and McAuliffe 2012). Up to 45% of pregnant women 
may under-report their food intake (McGowan and McAuliffe 2012). In a 
Swedish study of obese non-pregnant persons, up to 92% under-reported 
their energy intake (Johansson et al. 2001). In the same study, among 
normal-weight non-pregnant women the proportion of under-reporters was 
33%. Misreporting has probably produced some bias in the results of the 
present thesis. Under-reporting seems to concern especially foods with high 
fat content, whereas healthy foods, such as fruits and vegetables, may be 
over-reported (Hirvonen et al. 1997). This may bias the results closer to the 
nutrition recommendations than they are in reality. The HFII scores may 
thus be over-estimates, not reflecting the true quality of the diet. The finding 
that differences in HFII scores varied with participant characteristics 
according to the theory suggests that the HFII ranked participants correctly. 
Sometimes misreporting is assessed by the ratio of energy intake to basal 
metabolic rate (BMR) (Black 2000). In the present thesis, this was not done 
because of the lack of valid methods for calculating BMR in obesity and 
pregnancy. Thus, BMI- and pregnancy-related bias may also be present in 
the results. 
During pregnancy most women experience some nausea and vomiting, 
especially during the 1st half of pregnancy (Lacroix et al. 2000). This may 
affect appetite and food choices (Latva-Pukkila et al. 2010). Depending on 
the length of the nausea period, this could distort the picture provided by the 
94 
 
three-day diet record and the FFQ of the diet. During late pregnancy women 
often experience gastroesophageal reflux (Malfertheiner et al. 2015), which 
may affect eating behaviour. These factors produce within-person variation 
in the diet throughout pregnancy. That is why we cannot expect perfect 
reproducibility when measuring diet by 1st and 2nd trimester FFQs. Since 
dietary patterns seem to change little from pre-pregnancy through early to 
late pregnancy (Cuco et al. 2006, Crozier et al. 2009a), evaluating 
reproducibility of the HFII during pregnancy was reasonable. In Study II, we 
performed the reproducibility analysis in the control group only to minimize 
the presence of variation due to dietary change. Obviously, some within-
person variation occurs regardless. In Study IV, the dietary variation caused 
by the intervention added to the smaller natural variation present in the 
control group. Thus, it is justified to study change within the same time 
interval that we measured reproducibility. 
6.2.5. ASSESSING ADEQUATE NUTRIENT INTAKE 
When assessing adequacy of nutrient intake, instead of recommended daily 
intake, a good reference would be average nutrient requirements (Ribas-
Barba et al. 2009). Both the FNR and the NNR, however, lack average 
nutrient requirements for pregnant women (Nordic Council of Ministers 
2014). Concerning Studies I and II, comparison of nutrient intake with the 
RI may result in misinterpretation of the adequacy of intake because the 
requirements are lower than the recommended levels for almost all 
individuals. Regardless of the certain mean intake on a population level, 
individuals may have inadequate or adequate intakes, and thus, no 
conclusions about adequacy can be drawn.  
6.2.6. DIET QUALITY INDEX 
Utilizing an a priori diet score potentially enables comparability between 
studies and over time. Utilizing population specific cut-offs, such as those 
used in the HFII, limits comparability between studies and populations. The 
HFII takes into account the complexity of foods. On the other hand, diet 
quality indices, including the HFII, rarely measure all dietary aspects 
(Waijers et al. 2007). It may ignore some dietary aspects relevant to GDM. 
This could have attenuated the association between diet and GDM. In 
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addition, exclusion of red and processed meat may have impaired the 
accuracy of the HFII. Red and processed meat may increase the risk for 
chronic conditions such as T2D (Song et al. 2004) and GDM (Zhang et al. 
2006a). However, the HFII identifies similar dietary factors as those earlier 
shown to be associated with GDM, namely vegetables, fruits, quality and 
quantity of fat, high-energy/nutrient-poor foods (Zhang et al. 2006a, 
Schoenaker et al. 2015, He et al. 2015, Tryggvadottir et al. 2016). 
General problems of dietary indices, i.e. subjective interpretations in scoring, 
setting cut-off limits, and weighing, concern also the HFII (Waijers et al. 
2007). The subjective decisions may have resulted in some suboptimal 
scorings, for example, in the case of the snacks component. It had a low item-
rest correlation coefficient, which may reflect a flaw within the component 
scoring. The scores of the Snacks, however, linearly reflected nutrient intakes 
closer to the NNR with higher scores. However, the subjective decisions may 
have caused bias for the association between the HFII and the nutrient 
intakes in the validity analysis of Study II.  
The HFII was not originally designed for measuring dietary change, and we 
did not evaluate the HFII components’ capability to measure change. The 
components may not measure change equally. For example, decreasing the 
frequency of snacks (candy, pastry, chocolate, chips, and ice cream) from four 
times to zero times a week does not produce a change in the HFII score. 
Similarly, if one consumes vegetables once a day at baseline and increases it 
to twice a day, the HFII score remains unchanged. Because the HFII did not 
cover total dietary patterns, some relevant dietary changes may have gone 
undetected. Subtle changes remaining unnoticed may cause differences in 
the ability of the HFII sub-indices to detect changes. Thus, interpreting the 
results of the association between the sub-indices and GDM requires caution. 
A major strength of the HFII is that it made detailed nutrient-intake data 
unnecessary (Kant 1996). Nutrition recommendations in Western countries 
resemble each other (WHO Regional Office for Europe, Nutrition and Food 
Security programme 2003), and therefore, the HFII with minor adaptions in 
the food groups could also be used in other Western countries. Food 
guidelines for pregnant and non-pregnant populations are also similar 
(Nordic Council of Ministers 2014), and thus, the HFII could also be suitable 
for other adult populations. 
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6.2.7. EVALUATION OF VALIDITY OF HEALTHY FOOD INTAKE INDEX 
The studies for validating diet quality indices thus far have varying methods 
and types of validity that they measured (McNaughton et al. 2008, Guenther 
et al. 2014, Collins et al. 2015). A strength of Study II was that the validity 
was assessed from several perspectives. Probably the most thoroughly 
evaluated diet quality index is the Healthy Eating Index (Kennedy et al. 1995, 
Hann et al. 2001, Guenther et al. 2008, Guenther et al. 2014). We set five 
similar questions for testing the properties of the HFII as Guenther et al. 
(Guenther et al. 2014) for the Healthy Eating Index-2010, and two additional 
questions concerning reproducibility and components’ independency of each 
other. We took approaches and used methods that were novel for nutrition 
research (item analysis, association of individual index components with 
nutrient intake presented in Supplemental Figure 1), but which brought more 
information on the correlational structure and the role of each component to 
the total index, which have been missing in many studies of indices (Waijers 
et al. 2007). In the cases of dietary index and the underlying FFQ, 
reproducibility measures over a long period account for both measurement 
error and within-person variation. This is not, however, considered a major 
problem when the topic of interest is long-term diet because both 
measurement error and within-person variation produce misclassification of 
true intake (Willett 2012). Thus, it is justified to measure reproducibility by 
dietary index/FFQ measured three months apart. 
6.2.8. DIAGNOSIS OF GESTATIONAL DIABETES MELLITUS 
The GDM diagnosis procedure followed the national standards (Finnish 
Medical Society Duodecim 2014), and the thresholds for OGTT were only 
slightly modified from the guidelines of WHO (Guideline Development 
Group of World Health Organization 2013) and IADPSG (International 
Association of Diabetes and Pregnancy Study Groups Consensus Panel et al. 
2010), which are widely used internationally. The diagnostic procedure is 
thus comparable with the international criteria. In the three relevant 
published studies of indices in relation to GDM (Tobias et al. 2012, Zhang et 
al. 2014, Bao et al. 2014a), the diagnostic criteria were different from that of 
the present thesis. Diagnosis in the above-mentioned studies followed the 
criteria of Carpenter and Coustan (1982), i.e. the two-step 100 g OGTT 
method. Because the diagnosis requires two abnormal values, the method 
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probably detects those with more serious GDM, whereas the criteria used 
here requires one abnormal value, thus possibly detecting also women with 
less severe GDM. This has led to a higher prevalence of GDM in this thesis, 
requiring a smaller sample size than in studies with a lower prevalence. 
Excluding women with GDM at 1st trimester from Studies III and IV ensured 
that the diet was unaffected by the GDM diagnosis, excluding the possibility 
of inverse causality. Although evidence of benefits of diagnosing GDM in the 
1st trimester is lacking (Guideline Development Group of World Health 
Organization 2013), women with higher fasting glucose and postprandial 
glucose concentrations at 1st trimester pregnancy are at higher risk for later 
pathological OGTT and adverse pregnancy outcomes (Bartha et al. 2000, 
Riskin-Mashiah et al. 2010). The procedure of excluding women with GDM 
at 1st trimester of pregnancy may have led to selection of less severe forms of 
GDM than in studies where this exclusion was not done.  
6.2.9. COVARIATE MEASUREMENTS 
Within the covariates, a weakness occurred in self-reported LTPA. Self-
reported physical activity may be an unreliable measure of the true physical 
activity (Evenson et al. 2012). So, the lack of more reliable measure of LTPA 
may have affected the association between the HFII and LTPA in Study II, 
and left some residual confounding in the results of the Studies III and IV. 
Instead of pre-pregnancy BMI, we used 1st trimester BMI because it was 
measured by a research nurse instead of self-report, and was thus considered 
more reliable (Holland et al. 2013). This may have caused some bias because 
some women suffer from oedema during the 1st trimester of pregnancy 
(Pisani et al. 2016), which may increase their weight but not affect their risk 
of GDM. The same may be true of the measure of weight change. 
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6.3. INTERPRETATION OF RESULTS 
6.3.1. NUTRIENT INTAKE OF PREGNANT WOMEN AT HIGH RISK OF 
GESTATIONAL DIABETES MELLITUS (STUDY I) 
Among the pregnant women, carbohydrate intake was lower and fat intake 
higher than in previous Finnish studies among pregnant women at high risk 
of GDM (Korpi-Hyovalti et al. 2012, Kinnunen et al. 2014). These differences 
probably reflect a trend of lower carbohydrate proportions in the diets of the 
Finnish population (Helldán et al. 2013). Misreporting of the sources of these 
nutrients may also contribute to the result (Pietilainen et al. 2010). However, 
the proportions of energy-yielding nutrients reflect the proportions of the 
general population. The macronutrient proportion may not be optimal for 
preventing GDM; intakes low in carbohydrate and high in total fat are 
associated with increased risk of GDM (Saldana et al. 2004, Bowers et al. 
2012).  
Pregnant women having mean total intake of vitamin D above the RI in the 
present thesis is a new finding in Finland. This can probably be attributed to 
the increasing awareness of the importance of vitamin D supplementation 
among pregnant women during the past decade (Aronsson et al. 2013), and 
to increased vitamin D fortification of Finnish dairy products. The pregnant 
women had intake of folate/folic acid above the RI valid at the time of the 
data collection (FNR 2005) (National Nutrition Council 2005) but below the 
new (in 2014) recommendation of 500 μg/day (National Nutrition Council 
2014). Thus, the recently announced nutrition recommendation of folic acid 
supplementation for women at reproductive age and women in early 
pregnancy was necessary (National Institute for Health and Welfare 2016). 
Sufficient intake of folate is especially important in early pregnancy 
(Ramakrishnan et al. 2012) and the recommended nutrient intake level of the 
NNR (Nordic Council of Ministers 2014) is thus higher for pregnant women 
than for the general population. As in previous studies, supplement use 
among pregnant women was high (Arkkola et al. 2006, Aronsson et al. 2013). 
Because of below-RI supply from food sources, supplementation with 
vitamin D and folic acid was probably justified. However, when assessed at a 
population level, the supplementation with vitamins C and E, and calcium 
was, although common, probably mainly unnecessary. The present thesis 
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cannot provide an estimation of adequacy of these vitamins and minerals at 
an individual level. The result of Study I suggests that some pregnant women 
at high risk of GDM may have insufficient intake of vitamin A. This is 
plausible because of the recommendation to avoid intake of foods with high 
content of vitamin A by the Finnish food safety authority (Lavikainen et al. 
2007). A German study established insufficient vitamin A intake and plasma 
levels in German pregnant women (Schulz et al. 2007), whereas in a Danish 
study pregnant women had high intakes of vitamin A (Maslova et al. 2014). 
Vitamin A deficiency may result in and exacerbate inflammation and impair 
immune function (Reifen 2002, Pino-Lagos et al. 2010). During pregnancy 
vitamin A is essential for development and growth of the foetus (Clagett-
Dame and DeLuca 2002). Sub-optimal vitamin A levels of pregnant women 
have been associated with spontaneous preterm delivery, anaemia, and 
pregnancy-induced hypertension (Radhika et al. 2002).  
6.3.2. HEALTHY FOOD INTAKE INDEX (STUDY II) 
The nutrient density increased when moving from a lower to a higher HFII 
category, while fat content decreased stepwise from lower to higher HFII 
categories. Other dietary indices measuring adherence to the NNR have 
performed similarly in reflecting nutrient intakes (Drake et al. 2011, Kanerva 
et al. 2014, Hillesund et al. 2014). The HFII scoring was associated with 
intake of sucrose, high intake being an indication of a low-quality diet and 
predicting development of overweight (Knudsen et al. 2013). The highest 
category of the HFII did not reflect sufficient intake of folate (500 μg/d) and 
vitamin D as per the recommended nutrition density of the NNR. The HFII, 
however, did not take into account supplement use, which, according to 
Study I, was high in the study population. A notable strength of the HFII is 
its independency of energy intake. The HFII does not measure quantity of 
food intake. The components that measured intake frequencies and habitual 
choices rather than amounts of intake probably contributed to the lack of the 
adverse consequence of providing higher scores for eating more food in 
general. Being able to avoid energy-adjustment contributes considerably to 
the usability of the HFII because it eliminates the need for detailed dietary 
data. The reproducibility measures of the HFII were similar to the few earlier 
reproducibility studies on food intake during pregnancy (Erkkola et al. 2001, 
Vioque et al. 2013).  
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The HFII measured three main dimensions of diet, “fat”, “healthy”, and 
“unhealthy” foods. These combinations in dietary patterns have also 
occurred in other studies (Uusitalo et al. 2009, Gorst-Rasmussen et al. 2011). 
The HFII-components were independent of each other in contributing to the 
total HFII, which was supported by the low item-rest correlation coefficients. 
The main finding of Study III that the HFII at 1st trimester was associated 
with glucose metabolism at 2nd trimester provides evidence of the HFII’s 
predictive validity. The main finding of Study IV that the HFII change during 
pregnancy may be associated with GDM suggests that the HFII is responsive 
to change. These results further support the validity of the HFII.  
6.3.3. NORDIC NUTRITION RECOMMENDATIONS AND 
GESTATIONAL DIABETES MELLITUS (STUDIES III AND IV) 
Study III: Although not significant, the effect estimates of the HFII-GDM 
association were of similar magnitude as in a study of the diet quality indices 
aMED, DASH, and aHEI compared with GDM (Tobias et al. 2012). The two 
other studies of dietary indices in relation to GDM have reported the results 
differently from ours, which complicates comparison (Zhang et al. 2014, Bao 
et al. 2014a). The direction of the association between aHEI and GDM was 
similar in a study by Zhang et al. (2014). The significant associations between 
the HFII and 2-hour glucose concentrations after OGTT also suggests that 
diet adherent to the NNR is a determinant for GDM risk in Nordic countries. 
This is further supported by the results of Study IV, indicating that a change 
towards the NNR between the 1st and 2nd trimesters of pregnancy lowers the 
risk of GDM. 
Because the HFII is an a priori specified index, it cannot conclude the diet 
most protective from high glucose concentrations. The studies of a posteriori 
dietary pattern analysis have found dietary patterns with similar 
characteristics as high scores in the HFII to be associated with a lower risk of 
GDM (Zhang et al. 2006a, Schoenaker et al. 2015, He et al. 2015, 
Tryggvadottir et al. 2016). So, the results of the present thesis are supported 
by the findings of the data-driven analysis.  
Dietary change during pregnancy for preventing GDM have earlier been 
studied mainly in diet or combined diet and exercise interventions (Tieu et 
al. 2008, Han et al. 2012, Bain et al. 2015). These intervention studies are the 
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most comparable to Study IV. A difference of Study IV relative to the 
unsuccessful interventions is inclusion of women with a history of GDM. 
These women may constitute a group with different mechanisms of 
pathophysiology in developing GDM (Huvinen et al. 2016, Grotenfelt et al. 
2016), and thus, different responsiveness to lifestyle intervention and 
lifestyle changes compared with overweight and obese women without prior 
GDM. Furthermore, most unsuccessful interventions have not tested and 
excluded women with pathological OGTT at baseline (Bain et al. 2015). In 
addition to the RADIEL study and Study IV of the present thesis, the GDM 
prevention study of Luoto et al. (Luoto et al. 2011) and that of Simmons et al. 
(Simmons et al. 2015) excluded women with pathological glucose 
concentrations at baseline. Unfortunately, Simmons et al. (Simmons et al. 
2015) did not have a control group, and the study of Luoto et al. (2011) was 
possibly underpowered for detecting a difference in GDM incidence between 
control and intervention groups.  
The results of Study IV suggest that the most important target of dietary 
change during pregnancy for GDM prevention may be the foods included in 
the HFII-Fat. The HFII-Fat components may also possess higher accuracy 
than the other components of the HFII. In Study II, the components of the 
HFII-Fat performed with slightly higher reproducibility than the other HFII 
components. Dietary choices between high- and low-fat as well as vegetable 
and animal fat products may remain more constant over time than the intake 
frequencies of foods, which is what the other components measured. 
Comparison of the sub-indices should thus be done with caution. 
6.3.4. MECHANISTIC RATIONALE FOR THE ASSOCIATION BETWEEN 
NORDIC NUTRITION RECOMMENDATIONS AND 
GESTATIONAL DIABETES MELLITUS 
Possible mediating factors of the association between the HFII and GDM 
could be nutrients of fruits and vegetables. Antioxidants, phytochemicals, 
dietary fibre, and micronutrients of fruits, berries, and vegetables may affect 
glucose metabolism and oppose free radicals and inflammation (Hamer and 
Chida 2007). High intake of fruits and vegetables may also have an influence 
by replacing red and processed meat or other harmful foods, as also 
discussed by Tobias and colleagues about DASH, aMed, and aHEI (Tobias et 
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al. 2012). Constituents of red and processed meat, such as saturated and total 
fat, heme iron, nitrites and nitrates, and advanced glycation end-products, 
have been associated with ß-cell damage, oxidative stress, and insulin 
resistance (Aune et al. 2009). A possible mediator is also vegetable protein, 
which has been associated with lower risk of GDM (Zhang et al. 2006a, Bao 
et al. 2013, Bao et al. 2014a). The vegetable component of the HFII included 
peas and legumes, high in vegetable protein, which may contribute to the 
association found between high HFII scores and lower risk of GDM. Whole-
grain foods are high in vitamins, minerals, and other bioactive compounds, 
and may mediate the association between diet adherent to the NNR and 
GDM (Fardet 2010).  
Improvement in the HFII-Fat would result in a decrease in intake of fats and 
SFA, as well as an increase in MUFA and PUFA. Other studies have also 
found results linking fat intake and GDM; intakes of fried food (Bao et al. 
2014b), and animal fat (Bowers et al. 2012, Bao et al. 2014a) have been found 
to be associated with higher risk of GDM. High intake of fat has been 
associated with glucose abnormalities during pregnancy (Moses et al. 1997, 
Saldana et al. 2004), possibly through impaired insulin sensitivity (Pinel et 
al. 2014) or through its effect on gut microbiota, which may affect 
inflammation and insulin resistance (Shen et al. 2014). The underlying 
mechanism for the possible effect of increased MUFA intake could be its 
beneficial impact on fasting glucose concentration (Schwab et al. 2014) or on 
insulin sensitivity (Paniagua et al. 2007). In addition, PUFA intake may 
reduce incidence of glucose intolerance (Wang et al. 2000) and inflammation 
(Lopategi et al. 2016) during pregnancy. 
 
103 
 
7. CONCLUSIONS AND IMPLICATIONS OF 
FINDINGS 
Pregnant women at high risk of GDM have excessive SFA in their diet, which 
may further increase their risk of GDM. This thesis produced a novel finding 
that, except for vitamin A, pregnant women have micronutrient intake at 
recommended levels when the diet is supplemented with vitamin D and folic 
acid. Another novel finding is the low intake of vitamin A in pregnant Finnish 
women at high risk of GDM. Further investigation of vitamin A status in 
pregnant Finnish women is warranted. 
Level of adherence to the NNR may be a determinant for developing GDM. 
The association should be confirmed in a larger study population in groups 
separated by different risk profiles. The finding of GDM risk lowering with 
higher adherence to the NNR is, however, supported by earlier results that 
diets high in vegetables, fruits, and whole-grain foods and low in high-
energy/nutrient-poor foods and animal fat may be protective against GDM. 
This thesis includes a unique study (Study IV) in which change in overall diet 
during pregnancy was associated with risk of GDM. This provides practical 
information for future prevention interventions. The results encourage 
identification of women who will benefit from lifestyle changes during 
pregnancy. These women should be provided with well-powered lifestyle 
interventions for GDM prevention with detailed measures of adherence to 
intervention and baseline glucose metabolism. For those who cannot benefit 
from lifestyle changes during pregnancy, other prevention strategies should 
be investigated.  
The aim to develop a diet quality index for measuring overall adherence to 
the NNR was successful. Firstly, the HFII covered all relevant food groups 
mentioned in the food guidelines of the NNR, excluding red and processed 
meat. Secondly, the nutrient intakes came closer to the RI of the NNR for all 
nutrients measured when moving towards the higher HFII categories. 
Thirdly, all components contributed to the HFII. Fourthly, demographic 
characteristics varied across the HFII categories meaningfully. In addition, 
the HFII measured change in adherence to the NNR. A novel feature 
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compared with other indices is that it is independent of energy intake. This 
feature widens its usability because it enables usage of less detailed dietary 
data than nutrient intake data. Thus, the HFII can be used without detailed 
dietary data or energy-adjustment in cohort and intervention studies for 
ranking the participants according to the level of adherence to the food 
guidelines of the NNR. The HFII can be used among overweight and obese 
pregnant women or pregnant women with a history of GDM. Similar food 
consumption and food guidelines apply in all Nordic countries so the HFII 
could be used in other Nordic countries as well. Moreover, since similar food 
guidelines apply for pregnant and non-pregnant populations (Nordic Council 
of Ministers 2014), the HFII could after validation also be suitable for other 
adult populations. 
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8. IMPLICATIONS OF THE THESIS 
Obese pregnant women and pregnant women with a history of GDM need 
proper dietary counselling. The counselling should include guidance on the 
amount and quality of fats, i.e. use of vegetable oils such as rapeseed or olive 
oil, and vegetable margarines. The counselling should include advice about 
safe sources of vitamin A, namely meat, eggs, and vegetables. Maternity 
clinics should continue to emphasize the importance of sufficient folic acid 
intake because of its essential role in preventing neural tube defects of the 
foetus (Ramakrishnan et al. 2012) and supporting other development 
throughout the pregnancy. Those pregnant women who do not take vitamin 
D and folic acid supplements need to be identified, monitored, and given 
dietary advice. In a setting with limited resources for performing a full dietary 
assessment, such as maternity clinics in Finland, use of the HFII as a quick 
screen of diet quality should be studied. 
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Supplemental Figure 1. Intake of nutrients in categories of the HFII components low-fat milk, fish, fat spread, snacks, and 
light cheese among pregnant Finnish women at high risk of gestation diabetes, Study II. Statistically significant at level 
*P<0.05, **P<0.01, ***P<0.001. SFA, Saturated fatty acids; PUFA, Polyunsaturated fatty acids; Suc., Sucrose; Vit D, 
Vitamin D. (Study II, n=443). 
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